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Muscle development and homeostasis are critical for normal muscle function. A key 
aspect of muscle physiology during development, growth and homeostasis is modulation of 
protein turnover. Protein turnover is the balance between synthesis and degradation of muscle 
proteins. The rate of protein degradation is the major factor underlying overall muscle growth 
during development. Protein degradation mainly takes place in the lysosome. The efficiency of 
lysosomal protein degradation depends upon lysosomal pH, which is generated and maintained 
by proton pumps. Despite the importance of protein degradation in muscle growth during 
development, the impact of dysregulated lysosomal pH on muscle development, growth, and 
homeostasis is unknown. Spns1, a highly conserved gene that encodes a putative late 
endosome/lysosome carbohydrate/H+ symporter, plays a pivotal role in maintaining optimal 
lysosomal pH. We used the zebrafish homozygous mutant spns1-/- to investigate the requirement 
for lysosomal pH during muscle development. Muscle development proceeds normally in spns1-/- 
embryos; however, spns1-/- larvae experience rapid loss of muscle integrity. We found that the 
developmental isoform of laminin (laminin-111) is re-expressed in spns1-/- muscle at a time when 
the mature isoform of laminin (laminin-211) is normally expressed. We showed that Sonic 
hedgehog (Shh) signaling can either promote or inhibit laminin-111 expression in muscle 
basement membranes in response to different genetic backgrounds and/or developmental times. 
		
To identify mechanisms upstream of laminin-111 re-expression, we focused on identifying the 
relevant laminin receptor. We found that laminin-111 re-expression is mediated by the laminin 
receptor integrin α6β1 (itga6b1) in spns1-/- larvae.  We detected increased activation of the 
intracellular protein FAK in response to itga6b1-mediated laminin-111 re-expression. We showed 
that muscle fiber detachments in spns1-/- larvae predominantly result from sarcolemmal 
instability. We detected increased expression of the cytokine TWEAK and matrix 
metalloproteinase MMP-9 in spns1-/- larvae. We showed that TWEAK induces expression of 
MMP-9 independent of NF-kB signaling. Finally, we provided evidence that inhibition of 
TWEAK signaling does not reduce muscle damage in spns1-/- larvae. This result contrasts with 
previous data showing that inhibition of TWEAK reduces muscle damage. Taken together, these 
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CHAPTER 1 
REVIEW OF THE LITERAURE 
1.1. Protein degradation in skeletal muscle 
A key aspect of muscle physiology during development, growth, and homeostasis is modulation 
of protein turnover. Protein turnover is the balance between synthesis and degradation of muscle proteins. 
Previous studies in chicken lines selected for fast and slow growth rates suggest that the rate of protein 
degradation is the major factor underlying overall muscle growth during development (Tesseraud et al., 
2000). Additionally, protein degradation has been shown to underlie muscle growth in most bony fish 
(Nemova et al., 2016). 
 The majority of protein degradation in vertebrates is carried out by three proteolytic systems: the 
proteasomal system, the lysosomal system, and the calpain system. The lysosomal and calpain systems 
predominate in fish, while the proteasomal and lysosomal systems predominate in mammals (Nemova et 
al., 2016). In fish skeletal muscle, calpains are responsible for 30-34% of protein degradation, while the 
lysosomal system is responsible for 40% of protein degradation (Lysenko et al., 2017). Calpains mediate 
selective degradation of cytosolic proteins (Nemova et al., 2016). In mammalian skeletal muscle, the 
lysosomal system accounts for 40% of protein degradation, while the proteasomal system accounts for 
50% of protein degradation (Zhao et al., 2007). Cytosolic, nuclear, and myofibrillar proteins are degraded 
through the proteasomal system; whereas the lysosomal system degrades membrane and extracellular 
proteins through endocytosis and cytosolic proteins and organelles through autophagy (Zhao et al., 2007).  
Adhesion of muscle fibers to their surrounding basement membrane is essential for muscle 
development and homeostasis. Despite being required for stable muscle cell adhesion, the muscle 
basement membrane is not static and is continuously remodeled throughout muscle development. The role 
that protein degradation plays in regulating basement membrane protein turnover during muscle 
development is not known. However, several lines of evidence suggest that there are reciprocal 
interactions between the basement membrane and lysosomal protein degradation (Carmignac et al., 2011; 
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Leonoudakis et al., 2014). Here, we will focus on the role of lysosomal protein degradation in muscle 
development and homeostasis. 
1.2. Lysosomal protein degradation  
The lysosome is a membrane bound organelle with an acidic interior. A well-known function of 
the lysosome is its ability to degrade macromolecules. Lysosomes can degrade macromolecules of intra- 
or extra-cellular origin. Intracellular macromolecules are delivered to the lysosome by different forms of 
autophagy; whereas extracellular macromolecules are delivered to the lysosome through the endocytic 
pathway. The lysosome harbors approximately 60 resident hydrolases that have different target substrates 
(Appelqvist et al., 2013). The best known lysosomal hydrolases are the cathepsin family of proteases. 
Cathepsins are categorized into three distinct groups according to the amino acid found in the active site: 
serine, cysteine, or aspartic acid. The most abundant lysosomal proteases include the aspartic cathepsin D 
and the cysteine cathepsins B, C, H and L. Cathepsins are optimally active in an acidic environment (pH 
4.5-5.0); therefore, the efficiency of lysosomal protein degradation depends upon lysosomal pH.  
1.2.1 Cathepsins 
 Protein degradation in skeletal muscle is dependent on cathepsin activity. Cathepsins D, B, H, and 
L are ubiquitous and constitute the predominant lysosomal proteases (Rossi et al., 2005).  Cathepsins 
function by binding and hydrolyzing target proteins. Cathepsin activity has been reported to play an 
important role in both muscle development and homeostasis. Previous data has shown that the aspartic 
cathepsins D and E and the cysteine cathepsins B and L are responsible for protein degradation in Salmon 
muscle (Yamashita and Konagaya, 1992). Cathepsin D is the predominant protease that mediates protein 
degradation in fish (Nemova et al., 2016). During muscle development, cathepsin B is required for 
myoblast fusion and differentiation. Previous reports have shown that cathepsin B is induced in C2C12 
myoblasts but is downregulated in myotubes (Gogos et al., 1996). Mutations in cathepsin D have been 
linked to muscle degeneration in human patients and zebrafish. Muscle degeneration is detected in muscle 
biopsies from patients with neuronal ceroid lipofuscinosis (CLN) type 10 caused by a mutation in 
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cathepsin D (Hersheson et al., 2014). Additionally, knock-down of cathepsin D in zebrafish leads to 
muscle degeneration (Follo et al., 2013). 
1.2.2. Lysosomal proton pumps 
Lysosomal pH is generated and maintained by lysosomal proton pumps. Optimal lysosomal pH is 
maintained by a vacuolar-type H+-ATPase (V-ATPase) that pumps protons into the lysosome, and 
multiple antiporters and symporters that move protons out of the lysosome (Graves et al., 2008; Sagné et 
al., 2001; Sasaki et al., 2017). V-ATPase is the primary driver of acidification within the endocytic 
pathway and the lysosome. Bafilomycin AI (BafA1), a specific inhibitor of V-ATPase, is able to block all 
lysosomal degradation that depends on the acidic pH; thus illustrating the requirement for V-ATPase in 
lysosomal protein degradation. Spns1, a highly conserved gene that encodes a putative late 
endosome/lysosome carbohydrate/H+ symporter, plays a pivotal role in maintaining optimal lysosomal pH 
(Rong et al., 2011). Previous studies have shown that loss of spns1 contributes to impaired cathepsin D 
activity; whereas increased spns1 promotes cathepsin D activity (Rong et al., 2011; Yanagisawa et al., 
2017). Recent data has reported that the proton pumps spns1 and V-ATPase work together to orchestrate 
optimal lysosomal acidification (Sasaki et al., 2017). 
1.3. Endocytic pathway 
Endocytosis is an important mechanism through which basement membrane remodeling is 
controlled (Rainero, 2016). Endocytosis involves the internalization of cell membrane and extracellular 
components, thus mediating the interactions between cells and their extracellular environment. 
Endocytosis can be achieved through a variety of processes and internalized components are destined for 
either recycling or degradation. Internalized components are first localized and sorted in a vesicle called 
the early endosome (EE). While some components are directed toward the plasma membrane through 
recycling compartments, others are destined for degradation. The degradation pathway involves the 
maturation of the EE into the late endosome (LE), which subsequently fuses with the lysosome. 
Degradation of cell membrane and extracellular components occurs in the lysosome, the terminal station 
for the endocytic pathway. pH is tightly regulated in the endocytic pathway: the early endosomes 
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maintain of pH of 6.0-6.5, while the late endosomes and lysosomes maintain a pH of 4.5-5.5 (Sorkin and 
von Zastrow, 2002). 
1.3.1. Endocytic pathway in muscle disease 
The endocytic pathway plays an important role in maintaining muscle fiber integrity. This is 
illustrated by previous studies showing that endocytic mechanisms are implicated in muscle disease 
caused by mutations in the following sarcolemmal proteins: Dysferlin, Caveolin -3 and α-sarcoglycan 
(Draviam et al., 2006; Hernández-Deviez et al., 2008). Mutations in Dysferlin and Caveolin-3 are 
associated with a number of muscle pathologies, including limb girdle muscular dystrophy type 2B and 
limb girdle muscular dystrophy 1C, respectively (Hernández-Deviez et al., 2008). It has been reported 
that Caveolin-3 blocks endocytosis of Dysferlin, thereby promoting the retention of Dysferlin at the 
sarcolemma. Loss of Caveolin-3 leads to the rapid internalization, and thus depletion, of Dysferlin from 
the sarcolemma (Hernández-Deviez et al., 2008). Mutations in α-sarcoglycan cause limb girdle muscular 
dystrophy 2D (Draviam et al., 2006). Previous data has shown that mutated α-sarcoglycan is unable to 
use the endocytic pathway that is required for its trafficking to and from the sarcolemma (Draviam et al., 
2006). Together, these data implicate a regulatory role of the endocytic pathway in muscle development 
and homeostasis. 
1.3.2. Endocytic control of Sonic hedgehog signaling 
Endocytosis involves the internalization of the plasma membrane along with transmembrane 
receptors and their ligands. Ligand-receptor binding often leads to rapid internalization of the ligand-
receptor complex, a process called receptor-mediated endocytosis (RME). RME is a central mechanism 
that can mediate many aspects of development. For example, RME mediates the Sonic hedgehog (Shh) 
signaling pathway, a key regulator of muscle development. The Shh signaling pathway is activated by the 
binding of the Shh ligand to its receptor Patched (Ptc). When Shh is absent, Ptc suppresses the activity of 
the protein Smoothened (Smo) by blocking the movement of Smo to the plasma membrane. The role of 
Smo is to activate downstream transcription factors and turn on target genes. Binding of Shh to Ptc leads 
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to the endocytosis of the Shh-Ptc complex, which allows Smo to move to the plasma membrane and 
activate downstream signaling. Shh ligands are predominantly recycled, whereas Ptc is moved from late 
endosomes into lysosomes for degradation (Christ et al., 2012). Dysregulation of lysosomal pH inhibits 
the late endosome/lysosome passage, thereby blocking RME. Previous data has shown that dysregulated 
lysosomal pH induced by the drug Choloquine blocks endocytosis of the Shh-Ptc complex. Chloroquine 
treatment results in the accumulation of Ptc at the cell surface and subsequent inhibition of Shh signaling. 
(Yue et al., 2014)  
Figure 1.1. Schematic of endocytic control of hedgehog signaling. A) Hedgehog (Hh) ligand is absent 
and Patched (Ptc) suppresses Smoothened (Smo). B) Hh ligand forms a complex with Ptc. Hh-Ptc 
complex is internalized through RME. Ptc is delivered to the lysosome for degradation and Smo moves to 
the cell surface.  
1.4. Lysosomes in muscle disease 
The pivotal role that lysosomes play in maintaining muscle homeostasis is demonstrated by 
autophagic vacuolar myopathies (AVMs) such as Pompe disease, Danon disease and X-linked myopathy 
(XMEA). In addition to AVMs, impaired lysosomal function has been implicated in other forms of 
muscle wasting including cancer cachexia, sarcopenia, denervation atrophy, disuse atrophy, and muscular 
dystrophies.  
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Pompe disease, Danon disease, and X-linked myopathy constitute a group of muscle disorders 
called autophagic vacuolar myopathies (AVMs). AVMs are characterized by the accumulation of 
dysfunctional lysosomes that occupy space in the muscle fibers, resulting in muscle fiber damage 
(Malicdan and Nishino, 2012). It is interesting to note that Danon disease and XMEA are characterized 
pathologically by unusual autophagic vacuoles with sarcolemmal features (AVSF). The membranes of 
AVSF harbor a variety of basement membrane and sarcolemmal proteins including laminin α2, integrin 
β1, α-dystroglycan, β-dystroglycan, fibronectin, and dystrophin. AVSF appear to be accumulations of 
lysosomes, yet the mechanism for their production is unknown. (Sugie et al., 2005) 
Impaired lysosomal function has also been linked to cancer cachexia, sarcopenia, denervation 
atrophy, disuse atrophy and muscular dystrophies. Abberant accumulation of autolysosomes in the 
skeletal muscle of cachexic cancer patients suggests a possible exhaustion of the lysosomal degradative 
capacity (Aversa et al., 2016). Aging studies have shown a correlation between age-related muscle 
wasting (sarcopenia) and a decline in lysosomal degradation in aged rat muscle (Wohlgemuth et al., 
2010). Mouse studies have shown that denervation of muscle leads to reduced muscle mass and over-
activation of the autophagic-lysosomal pathway (Vainshtein et al., 2015). In humans, it has been reported 
that muscle wasting due to short-term immobilization is attributed to impaired function of the autophagic-
lysosomal pathway (Bodine, 2013). Impaired lysosomal function is also implicated in muscular 
dystrophies. Dystrophin-related disorders, including Duchenne muscular dystrophy (DMD) and Becker 
muscular dystrophy (BMD), present evidence of impaired lysosomal function. BMD is characterized by 
increased number of lipofuscin granules in the myofibers, which is indicative of impaired lysosomal 
function (Momma et al., 2012).  
1.5. Muscle fiber-basement membrane interactions 
In muscle tissue, basement membranes both surround individual muscle fibers and concentrate at 
the myotendinous junction (MTJ), the site of force transmission from muscle to bone. Basement 
membranes are layered, sheet-like structures that are densely packed with extracellular matrix 
components. The extracellular protein laminin is a predominant component of the basement membrane 
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that is critical for muscle formation and homeostasis. Basement membranes act to anchor muscle fibers 
within the skeletal muscle tissue. Additionally, adhesion between muscle fibers and the basement 
membrane results in bi-directional signaling that is required for skeletal muscle viability and function. 
Disruption of this adhesion causes muscle diseases, thus emphasizing the importance of muscle fiber-
basement membrane adhesion for proper muscle development and homeostasis. 
1.5.1. Laminin expression in muscle 
Laminins are heterotrimeric proteins composed of α, β, and γ chains. Five α, four β, and three γ 
chains have been identified. 18 laminin isoforms exist, assembled from different combinations of the α, β, 
and γ chains. Laminin isoforms are named according to their chain composition. For example, laminin 
111 is composed of α1, β1, and γ1 chains. The α chain can be expressed and secreted as a single chain in 
the absence of the β and γ chains; β and γ chains are secreted only after the laminin-αβγ trimeric protein is 
assembled. Thus the α chain drives the secretion of its partners (Yurchenco et al., 1997). 
The isoform of the major laminin in the basement membrane changes during muscle development 
in amniotes and zebrafish (Gullberg, 1999; Hall et al., 2007). Laminin 111 is the major constituent during 
initial muscle development. After initial muscle development laminin 111 is replaced with laminin 211. 
This shift from laminin 111 to laminin 211 was first described in mouse and rat studies. The α1 chain in 
laminin-α1β1γ1 (lama1) is expressed at the MTJ in early mouse muscle development; however lama1 is 
not detected in normal adult mouse muscle (Falk et al., 1999; Patton et al., 1997). In contrast, the α2 chain 
in laminin-α2β1γ1 (lama2) is absent in rat muscle during prenatal development, but is expressed in both 
postnatal rat muscle and adult mouse muscle (Leivo and Engvall, 1988; Ringelmann et al., 1999). The 
laminin α1 chain is expressed in all basement membranes during embryogenesis; however its expression 
becomes more restricted as development proceeds (Tzu and Marinkovich, 2008). The replacement of 
laminin 111 with laminin 211 in zebrafish skeletal muscle has been well described. In zebrafish, 
expression of the laminin α1 chain is restricted to the eye, pectoral fins and neural structures in the head 
by 2 dpf.  In contrast, expression of the laminin α2 chain is restricted to the adaxial cells during late 
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somitogenesis and to the trunk muscle during later larval stages. The laminin α2 chain is maintained in 
the myotome at 2 dpf and 3 dpf. (Sztal et al., 2011) 
1.5.1.1. Laminin receptors 
Assembly of the laminin-rich basement membrane, attachment of the cell to the basement 
membrane, and bi-directional signaling are each influenced by the binding of laminin to its receptor. 
Laminin receptors are required for the anchoring and clustering of laminin at the cell surface, which 
promotes the polymerization and stabilization of the laminin scaffold. Laminin-bound receptors form a 
bridge between the internal actin cytoskeleton and the external basement membrane. Three laminin 
receptors are expressed in skeletal muscle: integrin α6β1, integrin α7β1, and dystroglycan.  Integrins are 
heterodimeric proteins composed of α and β subunits; different tissues express various combinations of 
the 18 α and 8 β chains (Shimaoka and Springer, 2003).  Integrin α6 (itgα6) shares homology with 
integrin α7 (itgα7), and both itgα6 and itgα7 form a complex with integrin β1 (Song et al. 1992). The first 
laminin receptor expressed during early embryonic development is integrin α6β1. Itgα6 is highly 
expressed in early myotubes in chick embryos, while itgα6 expression is unclear in adult muscle 
(Bronner-Fraser et al., n.d.). The expression of itgα7 is developmentally regulated by distinct mechanisms 
and corresponds to the expression of laminin-α2β1γ1 during secondary myogenesis in rat muscle 
(George-Weinstein et al., 1993). Dystroglycan is made of an α and β subunit that are translated from a 
single mRNA. Post-translational processing yields the two subunits. Dystroglycan is strongly expressed 
in both developing and adult tissues. (Barresi and Campbell, 2006) Dystroglycan can bind both laminin 
111 and laminin 211 (Talts et al., 1999). Both integrins and dystroglycan can compensate for each other 
and act as anchors to regulate assembly of the BM (Li et al., 2017).    
1.5.1.2. Sonic hedgehog-mediated laminin 111 expression 
Laminin111 is required for the assembly of the muscle basement membrane during initial muscle 
development. Laminin 111 self-assembly is the first step of basement membrane formation, a step that is 
required for the integration of other basement membrane components. Proper assembly of the basement 
membrane requires both the secretion and receptor-mediated anchorage of laminins (Li et al., 2017). Loss 
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of Sonic hedgehog (Shh) signaling in mice results in an abnormally patterned myotome, a phenotype that 
is caused by impaired basement membrane assembly. The authors of this study found that laminin α1 
gene expression is regulated by Shh signaling, and transcriptional activation of laminin α1 is affected 
when Shh signaling is lost. They found that Shh-induced expression of laminin α1 is needed to stimulate 
basement membrane assembly. (Anderson et al., 2009) A second study looking at laminin α1 expression 
in zebrafish found that laminin α1 expression is dependent on Shh signaling during early, but not late 
somitogenesis. They found that Shh signaling is necessary and sufficient to drive expression of the 
laminin α1 chain in zebrafish tailbud, pre-somitic and paraxial mesoderm (Pickering et al., 2017). 
Together, these two studies show that the regulation of laminin α1 by Shh signaling is conserved in 
vertebrates. 
1.5.2. Dynamic reciprocity 
The adhesive interaction between the muscle fiber and the basement membrane is mediated by 
two adhesion complexes, the Dystrophin-glycoprotein complex (DGC) and the integrin adhesion complex 
(IAC). As their names imply, the DGC contains the laminin receptor dystroglycan, while the IAC 
contains integrins α6β1 and α7β1. The complexes are formed through the binding of laminin to the 
extracellular domain of the receptor and the binding of intracellular adaptor proteins to the cytoplasmic 
domain of the receptor. Intracellular binding promotes the assembly of a large cytoplasmic protein 
complex that connects the laminin-rich basement membrane to the actin cytoskeleton. These adhesion 
complexes serve as signaling hubs that convey bi-directional information between the outside basement 
membrane and the inside of the muscle fiber. Signaling from the surrounding basement membrane 
generates changes within the fiber, and signaling from within the fiber alters the structure and makeup of 
the external basement membrane. This bi-directional co-regulation between the muscle fiber and the 
basement membrane is called dynamic reciprocity. (Bissell et al., 1982). 
Integrins can transition between an inactive conformation that has a low affinity for laminin 
binding and an active conformation that has a high affinity for laminin binding. This conformational 
change promotes the ability of integrin bi-directional signaling. The extracellular binding of laminin 
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induces signaling responses within the fiber known as outside-in signaling. On the other hand, the binding 
of intracellular proteins to integrin regulates the transition of integrin from an inactive conformation to an 
active conformation, thereby promoting extracellular laminin binding. This process is known as inside-
out signaling. 
Focal adhesion kinase (FAK) is a prominent intracellular adaptor protein that contributes to the 
formation of the protein complex that connects the basement membrane to the actin cytoskeleton. FAK is 
indirectly linked to the cytoplasmic domain of integrin. High levels of FAK phosphorylation promote 
muscle fiber-basement membrane adhesion, and adhesion to the basement membrane induces 
phosphorylation of FAK via integrin stimulation (Henry et al., 2001). Integrin binding to its extracellular 
ligands induces phosphorylation of FAK at tyrosine 397, thereby promoting increased FAK activity 
(Calalb et al., 1995; Guan et al., 1991; Hamadi et al., 2005). Additionally, integrin binding to its 
intracellular activators can induce polymerization of extracellular ligands (Goody et al., 2015; 
Vinogradova et al., 2002). In zebrafish muscle, FAK is highly phosphorylated between 24 – 30 hpf 
(Henry et al., 2001). 
1.5.3. Re-expression of embryonic components 
Although rare, a few studies have reported re-expression of embryonic components in mature 
tissues. As mentioned previously, the laminin α1 chain is expressed in all basement membranes during 
embryogenesis; however its expression becomes more restricted as development proceeds (Tzu and 
Marinkovich, 2008). One study detected increased expression of laminin α1 at the blood brain barrier in 
mice deficient for laminin α2, suggesting that laminin α2 deficiency led to increased laminin α1 
expression (Menezes et al., 2014). Another study looking laminin α2 deficient mice found that the loss of 
laminin α2 was associated with an increase in laminin α4 in the muscle basement membrane. In mice, 
laminin α4 expression in skeletal muscle is normally restricted to embryonic development. After birth, 
laminin α4 disappears from the muscle basement membrane. (Yurchenco et al., 2018) As previously 
described, the laminin receptor integrin α6β1 is also predominantly expressed during initial muscle 
development. Data has shown that integrin α6β1 expression is increased during regeneration in control 
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muscle; however its expression is primarily associated with non-muscle cells. In contrast, during 
regeneration in laminin α2 deficient muscle, increased integrin α6β1 expression is associated with both 
myotubes and non-muscle cells. Thus, the expression pattern of integrin α6β1 varies between laminin α2 
deficient muscle and control muscle during regeneration. (Sorokin et al., 2000) Taken together, these 
results suggest a possible connection between the loss of laminin α2 and the re-expression of embryonic 
components.  
1.6. MMP-9 
Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases, are known to 
cleave all extracellular matrix (ECM) proteins. MMP gene expression and activity is tightly regulated 
during development and homeostasis; however, changes in MMP expression and activity occur in many 
diseases (Brkic et al., 2015). MMP-9 is one of the most widely investigated MMPs.  MMP-9 plays a 
predominant role in the degradation of the ECM in a broad range of pathological conditions that require 
tissue remodeling. MMP-9 is capable of cleaving both ECM and adhesion components. MMP-9 is 
secreted as a zymogen that cannot cleave its substrates until it has been activated. The mechanism by 
which MMP-9 is secreted from a cell remains unknown.  MMP-9 can be activated by other MMPs, serine 
proteinases, nitric oxide and reactive oxygen species (ROS). MMP-9 activity can be inhibited by 
thrombospondins or TIMP-1. Interestingly, MMP-9 can form a complex with TIMP-1 prior to secretion, 
and MMP-9 is typically present as a zymogen in complex with TIMP-1. Additionally, TIMP-1 can both 
inhibit and activate MMP-9. (Reinhard et al., 2015) Interestingly, MMP-9 can affect integrin signaling 
through the degradation of laminin and other ECM components, thus exposing previously inaccessible 
integrin binding sites (Ethell and Ethell, 2007). 
In normal muscle, MMP-9 expression is restricted to initial muscle development. For example, in 
human muscle, MMP-9 is expressed until the stage of myoblast fusion in developing muscle; however, 
following myoblast fusion, MMP-9 is no longer expressed (Lewis et al., n.d.). In fact, it has been reported 
that expression of MMP-9 in muscle is only produced in response to treatment with cytokines, growth 
factors, or phorbol esters in vitro; whereas, MMP-9 is produced in response to factors released by 
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degenerating muscles in vivo (Morgan et al., 2010). For example, MMP-9 is expressed within 
degenerating muscle fibers in all inflammatory myopathies (Carmeli et al., 2004).  MMP-9 expression is 
also increased following injury. During muscle regeneration, MMP-9 likely plays a role in ECM 
degradation during both inflammation and satellite cell activation. Previous reports show that MMP-9 
mRNA expression is detected in both inflammatory cells and activated satellite cells in injured muscle 
(Chen and Li, 2009). Data has also shown that denervation results in elevated levels of MMP-9 in 
fibroblast-like cells that infiltrate into mouse gastrocnemius muscle (Ogawa et al., 2005). Additionally, 
data suggests that zebrafish older than 19 hpf express MMP-9 specifically in neutrophil/heterophil 
granulocytes that migrate in response to trauma (Yoong et al. 2007). 
MMP-9 mRNA expression pattern has been well described in zebrafish. In zebrafish, strong 
MMP-9 expression is first detected at 12 hpf in the notochord. By 14-15 hpf, MMP-9 expression is 
detected in both the notochord and the anterior mesoderm. However, by 17-19 hpf, MMP-9 expression is 
no longer detected in the notochord or the anterior mesoderm.  By 24 hpf, MMP-9 expression is only 
detected in the circulatory system, around the yolk, and around the head. From 2-9 dpf, MMP-9 
expression is restricted to the head region. In adult zebrafish, increased MMP-9 expression is detected 
only in the spleen. (Yoong et al., 2007) Similar MMP-9 expression patterns have been observed in carp 
and catfish (Chadzinska et al., 2008; Ke et al., 2015; Yeh and Klesius, 2008) 
1.6.1. MMP-9 in Duchenne Muscular Dystrophy  
 With the exception of rapid gene expression and activation of MMP-9 in response to injury, 
MMP-9 expression is normally restricted to embryonic development. MMP-9 is largely dormant in 
mature tissue; however, many disease states are characterized by the persistent presence of MMP-9. 
Within the last decade, it has become increasingly clear that MMP-9 is a critical regulator of disease 
progression in Duchenne Muscular Dystrophy (DMD). DMD is caused by mutations in the dystrophin 
gene, which encodes a critical component of the dystrophin-glycoprotein complex (DGC) previously 
described. Deficiency of dystrophin results in disruption of the DGC, sarcolemmal instability, and muscle 
fiber degeneration. The DGC protects the integrity of the sarcolemma, and loss of sarcolemmal integrity 
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in dystrophin-deficient muscle is characterized by micro-tears in the sarcolemma that leads to calcium 
influx and subsequent fiber degeneration (Hathout et al., 2016). Several lines of evidence show that loss 
of dystrophin leads to the activation of secondary mechanisms including calcium influx, infiltration of 
muscle tissue by inflammatory immune cells, accumulation of cytokines, activation of proteolytic 
enzymes, and impaired function of the autophagic-lysosomal pathway (Reviewed by Ogura et al., 2014). 
Increased levels of MMP-9 are associated with the pathogenesis of DMD in the mdx mouse 
model, the canine X-linked muscular dystrophy in Japan (CXMDJ) model, and muscle biopsies from 
human DMD patients (Fukushima et al., 2007; Kherif et al., 1999; Nadarajah et al., 2011). It has been 
reported that MMP-9 protein detected in skeletal muscle of mdx mice is enzymatically active (Li et al., 
2009). Increased MMP-9 levels correlate with DMD disease progression; therefore MMP-9 likely plays a 
role in the pathological mechanism of DMD.  For example, increased MMP-9 exacerbates muscle damage 
in mdx mice, while blocking its expression reduces muscle damage (Dahiya et al., 2011; Nadarajah et al., 
2011). Interestingly, one study found that blocking MMP-9 in mdx muscle led to decreased muscle 
necrosis and increased regeneration at the early disease stage; however, long term effects of blocking 
MMP-9 in mdx mice included skeletal muscle atrophy and weakness at the late dystrophy stage (Shiba et 
al., 2015). Aberrant MMP-9 expression has been well documented in mdx mice. One study reported that 
mdx mice show significantly higher levels of MMP-9 in diaphragm muscle compared with their WT 
siblings. The authors of this study showed that MMP-9 protein is found at elevated levels in both mdx 
mice and control mice between one-two weeks post birth. However, after two weeks, the MMP-9 protein 
levels were significantly decreased in control mice, while MMP-9 protein levels remained elevated in the 
diaphragm of mdx mice from three-eight weeks post birth. (Li et al., 2009) 
Blocking MMP-9 activity greatly improves muscle structure and function in mdx mice. Loss of 
MMP-9 expression leads to improved muscle structure and contractile function, reduced inflammation 
between muscle fibers, and reduced fiber necrosis in skeletal muscle of mdx mice (Li et al., 2009). Cell-
impermeable Evans blue dye (EBD) is used widely to study cell membrane permeability. EBD is marker 
of muscle fiber damage, as it is only taken up by muscle when sarcolemmal integrity is compromised. 
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EBD has been used to identify damaged muscle fibers in mdx mice caused by sarcolemmal instability. It 
has been reported that loss of MMP-9 leads to a reduction in EBD-positive fibers in mxd mice; therefore 
loss of MMP-9 rescues sarcolemmal integrity in the context of DMD. These findings suggest that 
sarcolemmal disruptions in mdx mice are attributed to increased levels of MMP-9. Additionally, the 
authors of this study found that loss of MMP-9 leads to improved regeneration of injured fibers and 
increased count of satellite cells in mdx mouse muscle. (Li et al., 2009) The rescue effects of MMP-9 
deficiency in mdx mouse muscle clearly implicate a role for MMP-9 in the pathological mechanism of 
DMD.  
Although the mechanism of action for MMP-9 in dystrophin-deficient muscle is still unclear, 
previous studies using the mdx mouse model have suggested mechanisms by which MMP-9 may promote 
muscle damage.  Data has provided evidence of elevated levels of the secreted glycoprotein osteopontin 
(OPN) and the cytokine TGF-β in circulation of mdx mice and DMD patients. In dystrophin-deficient 
muscle, elevated MMP-9 expression is induced by increased levels of OPN (Shiba et al., 2015). In turn, 
MMP-9 proteolytically cleaves and activates TGF-β. MMP-9-induced activation of TGF-β is evidenced 
by increased levels of TGF-β in the diaphragm muscle of mdx mice. Additionally, loss of MMP-9 leads to 
decreased levels of TGF-β in mdx mouse muscle (Dahiya et al., 2011; Nadarajah et al., 2011; Zanotti et 
al., 2007). Elevated activity of the NF-κB transcription factor is also detected in skeletal muscle of mdx 
mice. The MMP-9 promoter region contains a binding sequence for NF-κB, and selective inhibition of 
NF-κB in mdx mice results in significantly decreased levels of MMP-9 protein in the diaphragm (Shiba et 
al., 2015). These findings suggest that the elevated levels of MMP-9 in mdx mouse muscle are regulated 
by the activation of NF-κB. Interestingly, it’s been shown that loss of MMP-9 results in elevated 
macrophage infiltration and decreased neutrophil infiltration in dystrophin-deficient muscle (Shiba et al., 
2015). Additionally, it has been reported that MMP-9 targets and cleaves β-dystroglycan, key component 
of the DGC. It was previously suspected that MMP-9-induced cleavage of β-dystroglycan disrupts 
adhesion between the muscle fiber and the basement membrane, thereby causing muscle degeneration. In 
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fact, decreased protein levels of both β-dystroglycan and α-dystroglycan have been detected in mdx mice. 
However, it has recently been shown that inhibition of MMP-9 does not significantly reduce the cleavage 
of β-dystroglycan in dystrophin-deficient muscle. This result suggests the involvement of additional 
protease(s) causing cleavage of β-dystroglycan in DMD. (Shiba et al., 2015) 
1.6.2. TWEAK and MMP-9 in muscle pathology 
 Tumor necrosis factor (TNF)-related weak inducer of apoptosis (TWEAK) is pro-inflammatory 
cytokine that belongs to the TNF superfamily. TWEAK is a potent skeletal muscle-wasting cytokine. 
TWEAK is detected in several forms of muscle atrophy including myotonic dystrophy type I (DMI), 
inclusion-body myositis, denervation, disuse, tumor-induced cachexia, and aging (Johnston et al., 2015; 
Mittal et al., 2010; Morosetti et al., 2012; Tajrishi et al., 2014; Yadava et al., 2016). Depletion of 
TWEAK reduces muscle damage, while increased TWEAK aggravates muscle damage (Dogra et al., 
2007; Johnston et al., 2015; Mittal et al., 2010; Tajrishi et al., 2014; Yadava et al., 2016). For example, a 
previous study showed that TWEAK-Tg mice show decreased muscle fiber size, while TWEAK-NO mice 
show increased muscle fiber size. Interestingly, the authors of this study found that denervation-induced 
muscle atrophy is increased in TWEAK-TG mice and rescued in TWEAK knock out mice. (Mittal et al., 
2010) Another study using the mouse model of DMI showed that the depletion of TWEAK rescues 
muscle damage; whereas administration of the soluble TWEAK protein aggravates muscle damage in the 
mouse model of DM1 (Yadava et al., 2016). Additionally, inhibition of TWEAK-Fn14 signaling has been 
shown to block tumor-induced cachexia in mice (Johnston et al., 2015). 
In addition to its marked expression in DMD, MMP-9 is strongly detected in muscle wasting 
conditions such as DMI, aging, and disuse (Reznick et al., 2003; Tajrishi et al., 2014; Yadava et al., 
2016). Several lines of evidence suggest that TWEAK induces skeletal muscle damage through increased 
expression of MMP-9. For example, studies using MMP-9 knock-out mice have found that MMP-9 
expression is required for TWEAK-induced muscle atrophy, inflammation, necrosis, and basement 
membrane degradation (Li et al., 2009; Vandooren et al., 2013). Additional studies have reported the 
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requirement of TWEAK activation for increased MMP-9 expression and muscle atrophy in mouse models 
of DMI and aging (Tajrishi et al., 2014; Yadava et al., 2016).  
1.6.3. TWEAK-Fn14 signaling axis 
TWEAK-induced signaling involves the binding of TWEAK to its receptor, fibroblast growth 
factor-inducible 14 (Fn14), followed by the recruitment and binding of the adaptor protein, tumor necrosis 
factor receptor-associated factor (TRAF), to the cytoplasmic tail of Fn14 (Figure 1.2.). Recruitment and 
binding of TRAF is essential for TWEAK-induced signaling (Schiaffino et al. 2013). TWEAK-induced 
recruitment of the cIAP2-TRAF2 complex to the Fn14 cytoplasmic tail leads to cathepsin-dependent 
lysosomal degradation of TRAF2 and cIAP2 (Vince et al., 2008). TWEAK-induced degradation of the 
cIAP1/2-TRAF2 complex stabilizes NF-κB inducing kinase (NIK) and induces NF-kB activity (Vince et 
al., 2008). TWEAK induces MMP-9 gene expression through the activation of NF-kB and AP-1 signaling 










     





1.7. Spinster (spns1) 
Spns1 is a highly conserved gene that encodes a putative late endosome/lysosome 
carbohydrate/H+ symporter called spinster (spns1). Spns1 plays a pivotal role in maintaining optimal 
lysosomal pH (Rong et al., 2011). The role of spns1 in tissue development and homeostasis has 
predominantly been studied in the Drosophila nervous system. Loss of spns1 leads to modifications of the 
nervous system characterized by the presence of lipofuscin, oxidative stress, sustained TGF-β signaling, 
and excessive accumulation of dysfunctional lysosomes (Dermaut et al., 2005; Milton et al., 2011; 
Sweeney and Davis, 2002). Spns1 expression is detected in both nerves and muscle of Drosophila, and 
the loss of spns1 leads to excessive accumulation of lysosomes and activation of the JNK/AP-1 signaling 
pathway in muscle (Milton et al., 2011; Sweeney and Davis, 2002). In zebrafish, spns1-/- mRNA is 
detected in the yolk cell from 24 hpf - 48 hpf and at the interface between the dorsal yolk and the 
overlying tissues from 48 hpf - 96 hpf (Young et al., n.d.). Additionally, spns1-/- zebrafish present 
extremely high levels of senescence associated-β galactosidase (SA-β gal) activity at 3.5 dpf (Kishi et al., 















MUSCLE DEGENERATION IN A ZEBRAFISH MODEL OF LYSOSOMAL RELATED 
MYOPATHY 
2.1. Introduction  
Muscle development and homeostasis are critical for normal muscle function. A key aspect of 
muscle physiology during development, growth, and homeostasis is modulation of protein turnover. 
Protein turnover is the balance between synthesis and degradation of muscle proteins. Previous studies in 
chicken lines selected for fast and slow growth rates suggest that the rate of protein degradation is the 
major factor underlying overall muscle growth during development (Tesseraud et al., 2000). Protein 
degradation mainly takes place in the lysosome, a principal proteolytic system that accounts for more than 
98% of long-lived bulk protein turnover in skeletal muscle (Rajawat et al., 2009). The efficiency of 
lysosomal protein degradation depends upon lysosomal pH. This dependence is because lysosomal 
protein degradation requires cathepsins that are optimally active at a pH of 4.5-5. Lysosomal pH is 
generated and maintained by lysosomal proton pumps. Despite the importance of protein degradation in 
muscle growth during development, the impact of dysregulated lysosomal pH on muscle development, 
growth, and homeostasis is unknown. 
Adhesion of muscle fibers to their surrounding basement membrane is essential for muscle 
development and homeostasis. Despite being required for stable muscle cell adhesion, the muscle 
basement membrane is not static. There is dynamic assembly and turnover of laminin, a heterotrimeric 
protein that is a major component of the basement membrane. The isoform of the major laminin in the 
basement membrane changes during muscle development in amniotes and zebrafish (Gullberg, 1999; Hall 
et al., 2007). Laminin 111 is the major constituent during initial muscle development. After initial muscle 
development laminin 111 is replaced with laminin 211. The role that autophagic/endocytic pathways play 
in regulating basement membrane protein turnover during muscle development is not known. However, 
several lines of evidence suggest that there are reciprocal interactions between laminin and the 
autophagic/endocytic pathways. The laminin receptor dystroglycan plays a role in regulating the 
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endocytosis of laminin 111 that is targeted to lysosomes for degradation in mammary epithelial cells 
(Leonoudakis et al., 2014). Interestingly, autophagy is differentially disrupted in two muscular 
dystrophies that result from mutations in extracellular matrix proteins. Whereas autophagy is increased in 
laminin α2 mutant mice and inhibition of autophagy rescues the phenotype; autophagy is decreased in 
collagen VI mutant mice and potentiation of autophagy rescues the phenotype (Carmignac et al., 2011). 
Taken together, the above data clearly indicate that the autophagic/endocytic pathways and cell adhesion 
interact, but the consequences of altered lysosome function on the extracellular matrix during muscle 
development are not known.  
Zebrafish are an excellent model for studying muscle development. We used the zebrafish mutant 
spns1-/- to investigate the requirement for lysosomal pH during muscle development. Spns1, a highly 
conserved gene that encodes a putative late endosome/lysosome carbohydrate/H+ symporter, plays a 
pivotal role in maintaining optimal lysosomal pH (Rong et al., 2011). Disruption of Spns1 has been 
shown to cause excessive lysosomal accumulation and increased senescence in zebrafish embryos (Sasaki 
et al., 2017).  
 In this study, we showed that dysregulated lysosomal pH disrupts muscle homeostasis and causes 
muscle degeneration. An important substructure in the muscle extracellular matrix is the myotendinous 
junction (MTJ). We found that laminin 111 was re-expressed at the MTJ in spns1-/- muscle around 3.5 
dpf.  Laminin 111 expression is normally regulated by Sonic hedgehog (Shh) signaling during initial 
muscle development; however we found that Shh is not required for laminin 111 re-expression in spns1-/- 
muscle. The mechanism of action for laminin 111 re-expression at the spns1-/- MTJ is mediated by the 
laminin receptor integrin α6β1. We found that integrin α6β1-mediated laminin 111 re-expression caused 
increased activation of the intracellular protein FAK. Similar to the zebrafish model of Duchenne 
Muscular Dystrophy (DMD), we found that muscle fiber detachments in spns1-/- larvae predominantly 
result from sarcolemmal instability. Given the correlation between DMD-induced muscle damage and 
increased levels of MMP-9, we investigated MMP-9 expression and detected upregulation of MMP-9 in 
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spns1-/- larvae. We found that TWEAK-induced gene expression of MMP-9 occurs in the absence of NF-
kB activation. Finally, we provide evidence that blocking TWEAK signaling does not ameliorate muscle 
damage in spns1-/- larvae.  Taken together, these results suggest that dysregulated lysosomal pH leads to 
altered expression of adhesion complex components at the MTJ, increased activation of the TWEAK 
signaling pathway, and sarcolemmal damage. 
2.2. Materials and Methods 
2.2.1. Zebrafish Husbandry/Mutant/Transgenic Lines 
 Zebrafish embryos were retrieved from natural spawns of adult zebrafish maintained on 14h 
light/10h dark cycle. Spns1hi891/h891 mutants were a generous gift from the Kishi lab at the Scripps 
Research Institute. Strains used in this study were spns1hi891/h891 (Kishi et al. 2008), spns1hi891/h891; 
dag1hu3072 (Lin et al., 2011), spns1hi891/h891; itga7-/+, and spns1hi891/h891; Tg(Nf-kB:EGFP)nc1 (Kanther et al., 
2011). Embryos were grown in embryo rearing media (1X ERM) with methylene blue at 28.5 degrees 
Celsius and staged according to (Kimmel et al., 1995). 
2.2.2. Morpholino Injections 
 Morpholinos (MOs) were obtained from Gene Tools, LLC. MOs were diluted in sterile water to a 
stock concentration of 1 mM. Two itga6 translation-blocking MOs had the following sequences: MO1 5’-
AGCTCCATTGCCTGAAATGAATG-3’ and MO2 5’-CTGTTGTATGAAAAATATAGCCCTT-3’. 
These two MOs were co-injected so that embryos received 9 ng MO1 and 8 ng MO2.  
2.2.3. Cyclopamine (CyA)/Aurintricarboxylic acid (ATA) Treatment 
 Embryos were treated with CyA to disrupt Sonic hedgehog (Shh) signaling. CyA dilution was 
chosen based on (Barresi et al., 2005). CyA (Toronto Chemical) was dissolved in 100% EtOH to a stock 
concentration of 5 mM. 250 ul of the 5mM stock was added to 25 mL of 1X ERM, bringing the final 
concentration to 50 uM CyA and 1% EtOH. Control embryos were treated with 1% EtOH.  
 Embryos were treated with ATA to disrupt TWEAK signaling. ATA dilution was chosen based 
on (Kurusamy et al., 2017). ATA (Sigma Aldrich) was dissolved in 100% EtOH to a stock concentration 
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of 100 mM. 50 ul of 100 mM stock was added to 50 ml of 1X ERM, bringing the final concentration to 
100 uM ATA and 0.1% EtOH. Control embryos were treated with 0.1% EtOH. 
2.2.4. Evans Blue Dye (EBD) Injection 
 Zebrafish were anesthetized in 0.16 mg/mL tricaine in 1X ERM and side mounted on 1% 
agarose-lined Petri dishes in minimal volume of liquid. EBD (1% w/v) was dissolved in a 0.9% saline 
solution. Injection needles were pulled from glass capillary tubes containing a filament on a Sutter 
Flaming/Brown Micropipette Puller. EBD solution was loaded into injection needles and injected into the 
circulation of anaesthetized ~72hpf zebrafish using a MMPI-3 pressure injector from ASI. EBD injected 
zebrafish were maintained in 1X ERM for approximately 12 h before live imaging. 
2.2.5. Phalloidin Staining and Immunohistochemistry 
 All antibodies (Abs) were diluted in block (5% w/v Bovine Serum Albumin (BSA) in Phosphate 
Buffered Saline (PBS) with 0.1% Tween20). Alexa 546 phalloidin (Molecular Probes) staining involved 
fixing embryos in 4% Paraformaldehyde (PFA) for 4h at room temperature (RT), washing 5 times for 5 
min each (5 x 5) in 0.1% PBS-Tween, permeabilizing for 1.5h in 2% PBS-Triton, washing 5 x 5 and then 
incubating in phalloidin (1:20) for 1-4h at RT. Ab staining followed phalloidin staining. Ab staining 
involved blocking for 1h at RT, incubating in 1° Ab overnight at 4 °C, blocking for 8h at RT, incubating 
in 2° Ab overnight at 4 °C, then washing for 1h. 1° Abs: anti-Laminin-111 1:50 (Sigma); anti-pY-397-
FAK 1:50 (Biosource); anti-beta-Dystroglycan 1:50 (Novocastra); anti-MMP-9 (GeneTEX). 2° Abs: 
GAM/GAR 488, 546, 633 1:200 (Invitrogen). 
2.2.6. Comparative qRT-PCR  
 RNA was isolated from whole embryos at 3.5 dpf via Quiagen’s RNeasy Mini Kit. One-step 
comparative qRT-PCR was conducted with Quanta kit reagents and SYBR® Green. A Mx400 machine 
was used and the annealing temperature was at 60 °C. Approximately 50 ng of RNA template was used 
per reaction. We used beta-actin as our normalizing transcript. See Table 2.1. for a complete list of primer 
information. See Table 2.2. for qRT-PCR results. 
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Table 2.1. Primer Sequences, Product Sizes and Concentrations 
Primer Sequence Product size Final conc. 
TWEAK forward 5’-TGAATATGAGCAGGGCAGT-3’ 20 base pairs 100 uM 
TWEAK reverse 5’-TTCAATGCACTGGAGCAAAG-3’   
MMP-9 forward 5’-TGATGTGCTTGGACCACGTAA-3’ 21 base pairs 100 uM 
MMP-9 reverse 5’-ACAGGAGCACCTTGCCTTTTC-3’   
MMP-2 forward 5’-CTGGACCCACAGTAAGCAAA-3’ 20 base pairs 100 uM 
MMP-2 reverse 5’-CCCCTTTATTAAATGCAGGA-3’   
 
Table 2.2. Quantitative Real-Time PCR Results 
Primer ∆∆ Cq Exponential Change 
TWEAK -5.09 34.12 
MMP-9 -3.92 15.12 
MMP-2 2.54 -5.82 
 
2.2.7. Imaging 
 Images were taken on an Olympus Fluoview IX-81 inverted microscope with FV1000 confocal 
system or a Leica TCS SP8 confocal system using the LASX Software. Embryos were side mounted in 
80% glycerol/20% PBS and viewed with the 20x or 25x objective. Exposure times were kept constant 
throughout the imaging of an experiment allowing for the comparison of fluorescent levels between 
images. Live imaging for EBD experiments involved side mounting ~3.5 dpf zebrafish embryos in 0.4% 
low melt agarose containing 0.16 mg/mL tricaine and imaging via confocal microscopy. 
2.2.8. Analysis and Statistics 
 NF-kB activity was quantified using mean grey values of fluorescent intensity based on (Lee et 
al., 2018). Fluorescent images were captured at 25x magnification. Fluorescence signal intensity was 
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determined using mean grey values with images converted to a pre-set grey scale (ImageJ). All image 
capturing and threshold parameters were kept constant between experiments.  
Categorical data were analyzed using R version 3.5.1 (www.r-project.org) using Fisher’s exact 
test. Immunohistochemistry data was visually scored. Relative fluorescence intensity was assigned a score 
of 0 (no staining), 1 (weak staining), or 2 (strong staining).  
Quantitative data were analyzed using Prism7.  Quantitative statistical comparisons of two groups 
were conducted using student t-tests. Quantitative statistical comparisons of multiple groups were 
conducted using ANOVA followed by Tukey’s honest significant difference multiple comparisons test.  
2.3. Results 
2.3.1. Normal initial muscle development 
The proton pumping action of lysosomal transporters, such as Spns1, regulates cathepsin activity. 
Previous data has shown that Spns1 regulates cathepsin D activity and cathepsin D knockdown leads to 
congenital myopathy in zebrafish (Follo et al., 2013; Rong et al., 2011). Thus, we asked whether muscle 
development is disrupted in spns1-/- larvae. We used fluorescent conjugated Phalloidin to stain F-actin in 
muscle fibers to investigate the impact of dysregulated lysosomal pH on muscle development. We stained 
spns1-/- mutants and WT controls with Phalloidin at 1 dpf, 2 dpf, 3 dpf, and 3.5 dpf. We found that muscle 
development was unaffected in spns1-/- mutants from 1 dpf - 3 dpf (Figure 1E1-G3). These results are 
consistent with previous data showing that spns1-/- zebrafish present a visible mutant phenotype beginning 
at 1 dpf, after primary muscle development is complete (Young et al., n.d.). We detected muscle fiber 
disorganization and detachments in spns1-/- mutants at 3.5 dpf (Figure 1H1-H3).  These results are 
interesting because spns1-/- mRNA expression has been reported to transition from the yolk cell to the 
interface between the dorsal yolk and the overlying tissues from 2 dpf - 4 dpf (Young et al., n.d.). 
Additionally, increased SA-beta-galactosidase activity, a marker of senescence, is detected in spns1-/- 
zebrafish at 3.5 dpf (Kishi et al., 2008). These data suggest that dysregulated lysosomal pH causes muscle 
damage following primary muscle development. 
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Figure 2.1. Normal initial muscle development and laminin 111 re-expression. (A1-H3) Anterior left, 
dorsal top, side-mounted embryos stained with phalloidin (pseudo-colored fuchsia) to visualize actin and 
anti-laminin-111 antibodies (green). Panels numbered 1 show images of phalloidin staining only. Panels 
numbered 2 show images of laminin-111 staining only. Panels numbered 3 show images of phalloidin and 
laminin-111 channels merged. (A1-A3) WT embryo at 1 dpf. Laminin-111 is localized to the MTJ. (B1-
B3) WT embryo at 2 dpf. Laminin-111 is localized to the MTJ. White arrowheads in A2-A3 and B2-B3 
point to laminin-111 localized to the MTJ. (C1-C3) WT embryo at 3 dpf. Laminin-111 is not detected at 
the MTJ. (D1-D3) WT embryo at 3.5 dpf. Laminin-111 is not detected at the MTJ. (E1-E3) Spns1-/- 
embryo at 1 dpf. Laminin-111 is localized to the MTJ. (F1-F3) Spns1-/- embryo at 2 dpf. Laminin-111 is 
localized to the MTJ. White arrowheads in E2-E3 and F2-F3 point to laminin-111 localized to the MTJ. 
(G1-G3) Spns1-/- embryo at 3 dpf. Fibers remain long and straight. Laminin-111 is very weak at the MTJ. 
(H1-H3) Spns1-/- embryo at 3.5 dpf showing wavy fibers and mild fiber detachments. Laminin-111 is 
localized to the MTJ. White arrowheads in H2-H3 point to laminin-111 localized to the MTJ. (I-J) 
Quantification of the percent of embryos at each of the four developmental time points that fell into each 
of the three categories of relative fluorescence intensity at the MTJ. (I) Strong laminin-111 staining at the 
MTJ in WT embryos at 1-2 dpf. Note laminin-111 staining is not detected at the MTJ in WT embryos at 
3-3.5 dpf. (J) Strong laminin-111 staining at the MTJ in spns1-/- embryos at 1-2 dpf and 3.5 dpf. Note 
very weak laminin-111 staining at the MTJ in spns1-/- embryos at 3 dpf. * p < 0.05, ** p < 0.01, *** p < 















2.3.2. Fast-twitch and slow-twitch fiber detachments  
 Fiber-type susceptibility to muscle damage varies between different muscle-related disorders 
(Talbot and Maves, 2016). Thus, we asked which fiber type is preferentially affected in spns1-/- muscle. 
Interestingly, both fast-twitch and slow-twitch fibers are damaged in spns1-/- larvae. There were no 
significant differences in the proportion of spns1-/- embryos that displayed fast-twitch fiber detachments 
vs. slow-twitch fiber detachments (p-value = 0.8018) (Figure A1D). The severity of muscle degeneration 
was also similar: there were no significant differences in the proportion of segments per embryo that 
displayed fast-twitch fiber detachments vs. slow-twitch fiber detachments (p-value = 0.5748) (Figure 
A1C). The above data indicate that both fast-twitch and slow-twitch muscles are damaged in spns1-/- 
larvae. However, muscle damage in individual spns1-/- larvae is usually restricted to one fiber type. The 
proportion of spns1-/- larvae containing only fast-twitch detachments or only slow-twitch detachments was 
significantly greater than spns1-/- larvae containing both fast-twitch and slow-twitch muscle fiber 
detachments (p-value = 0.0023, p-value = 0.0003, respectively) (Figure A1D). These data indicate that 
although both fiber types are susceptible to damage, fiber detachments in individual spns1-/- larvae tend to 
be restricted to a single fiber type. The mechanism mediating this effect is unknown. 
2.3.3. Re-expression of laminin-111 in spns1-/- 
 Muscle cells anchor to their surrounding laminin-rich basement membrane. Adhesion to laminin 
is critical for muscle and MTJ development and homeostasis. Disruption of muscle cell adhesion to 
laminin can affect muscle fiber-ECM attachment and cause muscle diseases (Goody et al., 2015; Jani and 
Schöck, 2007). Thus, we asked whether the adhesion protein laminin was altered in spns1-/- mutants 
compared with WT controls. We stained for laminin 111 in spns1-/- mutants and WT controls at 1 dpf, 2 
dpf, 3 dpf, and 3.5 dpf.  Relative laminin 111 staining intensity was strong at the MTJ in both spns1-/- 
mutants and WT controls at 1 dpf - 2 dpf (Figure 1A2-B3, E2-F3). Relative laminin 111 staining at the 
MTJ in WT controls was significantly weaker at 3.5 dpf compared to 1 and 2 dpf (p-values < 0.0001) 
(Figure 1I). There was no significant difference in relative laminin 111 staining at the MTJ in WT 
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controls at 3 dpf vs. 3.5 dpf (p-value = 0.4461) (Figure 1I). In spns1-/- mutants the relative laminin 111 
staining at the MTJ was significantly weaker at 3 dpf compared to 1 dpf (p-value = 0.006) (Figure 1J). In 
contrast to what we found in WT controls, relative laminin 111 staining was significantly stronger at the 
MTJ at 3.5 dpf compared to 3 dpf in spns1-/- mutants (p-value < 0.0001) (Figure 1J). In fact, there was no 
significant difference in the relative laminin 111 staining at the MTJ in spns1-/- mutants at 3.5 dpf vs. 1 
dpf (p-value > 0.9999) (Figure 1J).  These data indicate that laminin 111 is re-expressed in spns1-/- muscle 
at a time when it is not normally expressed in WT controls. 
2.3.4. Laminin-111 re-expression independent of Sonic hedgehog (Shh) signaling 
 Shh signaling is required for laminin 111 expression in developing muscle (Anderson et al., 
2009). Thus, we asked whether Shh signaling is also required for laminin 111 re-expression in spns1-/- 
muscle. Cyclopamine treatment blocks Shh signaling (Chen et al., 2002). We can regulate the timing of 
Shh signaling inhibition by administering cyclopamine at specific developmental stages. Shh signaling is 
required for myogenesis in zebrafish embryos; therefore we administered cyclopamine beginning at 2 dpf 
to avoid potential disruption of myogenesis (Feng et al., 2006). We treated spns1-/- and WT embryos 
continuously with 50 µM cyclopamine (with 1% EtoH) beginning at 2 dpf and fixed them at 3.5 dpf. 
Control spns1-/- and WT embryos were treated continuously with 1% EtOH beginning at 2 dpf and fixed 
at 3.5 dpf. We stained for laminin 111 in spns1-/- and WT larvae. Laminin 111 staining was detected at the 
MTJ in both control spns1-/- larvae and spns1-/- larvae treated continuously with 50 µM cyclopamine 
(Figure 2C-D3). There was no significant difference in the relative laminin 111 staining at the MTJ in 
spns1-/- larvae treated with cyclopamine vs. control spns1-/- larvae (p-value = 0.1838) (Figure 2F). 
Laminin 111 staining was not detected at the MTJ in WT control larvae at 3.5 dpf, while laminin 111 
staining was detected at 3.5 dpf in WT larvae treated with cyclopamine (Figure 2A-B3). The relative 
laminin 111 staining in WT larvae treated with cyclopamine was significantly stronger than the laminin 
111 staining in the WT controls (p-value < 0.0001) (Figure 2E). These data indicate that Shh is not 
required for laminin 111 re-expression in spns1-/- muscle and inhibition of Shh signaling beginning at 2 
dpf results in re-expression of laminin 111 in WT muscle. 
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Figure 2.2. Laminin 111 re-expression is independent of Shh signaling. (A-D3) Anterior left, dorsal top, 
side-mounted, 3.5 dpf larvae stained with phalloidin (pseudo-colored fuchsia) to visualize actin and anti-
laminin-111 antibodies (green). Lettered panels show phalloidin and laminin-111 channels merged. White 
boxes correspond to numbered panels on the right. Panels numbered 1 show zoomed-in images of 
phalloidin staining only. Panels numbered 2 show zoomed-in images of laminin-111 staining only. Panels 
numbered 3 show zoomed-in images of phalloidin and laminin-111 channels merged. (A-A3) WT control 
larva. Fibers remain long and straight. Laminin-111 is not detected at the MTJ. (B-B3) WT larva treated 
continuously with 50 µM CyA from 2 - 3.5 dpf. Fibers remain long and straight. Laminin-111 is localized 
to the MTJ. (C-C3) Spns1-/- control larva. Fibers are wavy and show mild detachments. Laminin-111 is 
localized to the MTJ. (D-D3) Spns1-/- larva treated continuously with 50 µM CyA from 2 - 3.5 dpf 
showing mild fiber detachments. Laminin-111 is localized to the MTJ. White arrowheads in B2-B3, C2-
C3, and D2-D3 point to laminin-111 localized to the MTJ. (E) Quantification of the percent of embryos 
that fell into each of the three categories of relative fluorescence intensity at the MTJ. WT larvae treated 
continuously with 50 µM CyA from 2 - 3.5 dpf show strong laminin-111 staining at the MTJ. (F) 
Quantification of the percent of embryos that fell into each of the three categories of relative fluorescence 
intensity at the MTJ. Strong laminin-111 staining at the MTJ in spns1-/- control larvae and in spns1-/- 
larvae treated continuously with 50 µM CyA from 2 - 3.5 dpf. * p < 0.05, ** p < 0.01, *** p < 0.001, 















2.3.5. Laminin 111 re-expression requires integrin α6β1 signaling 
 The deposition and polymerization of laminin in the basement membrane is regulated by laminin 
cell-surface receptors (Hamill et al., 2009). The three laminin receptors in skeletal muscle are 
dystroglycan, integrin α7β1 and integrin α6β1(Goody et al., 2012). We asked which laminin receptor is 
required for laminin 111 re-expression at the MTJ in spns1 muscle. Dystroglycan is encoded by the 
DAG1 gene. We generated DAG1;spns1 double mutants and stained for laminin 111 at 2 dpf, 3 dpf, and 
3.5 dpf. We generated itga7;spns1 double mutants and stained for laminin 111 at 2 dpf, 3 dpf, and 3.5 
dpf. An integrin α6 mutant was unavailable; therefore we injected itga6 MOs into spns1 embryos to 
generate itga6 MOs;spns1 mutants. We stained for laminin 111 in itga6 MOs;spns1 mutants at 1 dpf 
(n=4), 2 dpf, 3 dpf and 3.5 dpf. Relative laminin 111 staining intensity was strong at the MTJ in 
DAG1;spns1 and itga7;spns1 mutants at 2 dpf (Figure 3B1, C1). Relative laminin 111 staining intensity 
was strong at the MTJ in itga6 MOs;spns1 mutants at 1 dpf (not shown) and 2 dpf (Figure 3D1). Laminin 
111 staining was not detected at the MTJ in DAG1;spns1 and itga7;spns1 mutants at 3 dpf (Figure 3 B2, 
C2). We found that relative laminin 111 staining intensity was stronger at the MTJ in DAG1;spns1 and 
itga7;spns1 mutants at 3.5 dpf compared with laminin 111 staining at 3 dpf (p-value = 0.07, p-value = 
0.56, respectively) (Figure 3G-F). Notably, relative laminin 111 staining intensity in both DAG1;spns1 
and itga7;spns1 mutants showed no significant difference between 2 dpf and 3.5 dpf (p-value = 0.57, p-
value = 0.31, respectively) (Figure 3G-F).  We found that relative laminin 111 staining intensity was 
significantly weaker at the MTJ in itga6 MOs;spns1 mutants at 3.5 dpf compared with laminin 111 
staining at 1 dpf (n=4) (p-value =0.04) (Figure 3H). We also compared uninjected spns1 mutants to itga6 
MOs;spns1 mutants at 3.5 dpf (analysis not shown). We found that loss of itga6 significantly decreased 
relative laminin 111 staining at the MTJ in spns1 mutants (p-value = 0.02). Loss of itga6 did not effect 
laminin 111 staining in WT larvae (p-value > 0.9999) These data indicate that dystroglycan and integrin 
α7β1 are not required for laminin 111 re-expression in spns1 muscle; whereas integrin α6β1 is required 
for laminin 111 re-expression in spns1 muscle.  
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Figure 2.3. Laminin 111 re-expression is dependent on itga6. (A1-D3)  Anterior left, dorsal top, side-
mounted embryos stained anti-laminin-111 antibodies (green). Panels numbered 1 show images of 2 dpf 
embryos. Panels numbered 2 show images of 3 dpf embryos. Panels numbered 3 show images of 3.5 dpf 
larvae. (A1-A3) Spns1-/- control embryos / larvae. Laminin-111 is localized to the MTJ at 2 dpf and 3.5 
dpf. Note very weak laminin-111 staining at the MTJ at 3 dpf. (B1-B3) Dag1;spns1-/- double mutants. 
Laminin-111 is localized to the MTJ at 2 dpf and 3.5 dpf. Note laminin-111 is not detected at the MTJ at 
3 dpf. (C1-C3) Itga7-/-;spns1-/- double mutants. Laminin-111 is localized to the MTJ at 2 dpf and 3.5 dpf. 
Note very weak laminin-111 staining at the MTJ at 3 dpf. (D1-D3) Itga6 MOs;spns1-/- embryos / larvae. 
Laminin-111 is localized to the MTJ at 2 dpf. Note very weak laminin-111 staining at the MTJ at 3 dpf 
and 3.5 dpf. White arrowheads in A1, A3, B1, B3, C1, C3, and D1-D3 point to laminin-111 localized to 
the MTJ. (E) Quantification of the percent of embryos at each of the four developmental time points that 
fell into each of the three categories of relative fluorescence intensity at the MTJ. Strong laminin-111 
staining at the MTJ in spns1-/- embryos at 1-2 dpf and 3.5 dpf. Note very weak laminin-111 staining at the 
MTJ in spns1-/- embryos at 3 dpf. (F) Quantification of the percent of embryos at each of the three 
developmental time points that fell into each of the three categories of relative fluorescence intensity at 
the MTJ. Laminin-111 staining  is detected at the MTJ in dag1;spns1-/- embryos at 2 dpf and 3.5 dpf. Note 
laminin-111 staining is not detected at the MTJ at 3 dpf. (G) Quantification of the percent of embryos at 
each of the three developmental time points that fell into each of the three categories of relative 
fluorescence intensity at the MTJ. Laminin-111 staining  is detected at the MTJ in itga7-/-;spns1-/- 
embryos at 2 dpf and 3.5 dpf. Note very weak laminin-111 staining at the MTJ at 3 dpf. (H) 
Quantification of the percent of embryos at each of the four developmental time points that fell into each 
of the three categories of relative fluorescence intensity at the MTJ. Strong laminin-111 staining at the 
MTJ in itga6 MOS; spns1-/- embryos at 1-2 dpf. Note the majority of embryos / larvae showed very weak 





Figure 2.4. Increased FAK activity is dependent on itga6 signaling. (A-D3) Anterior left, dorsal top, side-
mounted, 3.5 dpf larvae stained with phalloidin (pseudo-colored fuchsia) to visualize actin and anti-pY-
397 FAK antibodies (green). Lettered panels show phalloidin and pY-397 FAK channels merged. White 
boxes correspond to numbered panels on the right. Panels numbered 1 show zoomed-in images of 
phalloidin staining only. Panels numbered 2 show zoomed-in images of pY-397 FAK staining only. 
Panels numbered 3 show zoomed-in images of phalloidin and pY-397 FAK channels merged. (A-A3) WT 
larva. Fibers remain long and straight. pY-397 FAK is not detected at the MTJ. (B-B3) Itga6 MOS; WT 
larva showing pY-397 FAK localized to the MTJ. (C-C3) Spns1-/- larva showing pY-397 FAK localized 
to MTJ. Note wavy fibers and fiber detachments. (D-D3) itga6 MOS; spns1-/- larva showing wavy and 
disorganized fibers. Note very weak pY-397 FAK localized to the MTJ. White arrowheads in B2-B3 and 
C2-C3 point to pY-397 localized to the MTJ. (E) Quantification of the percent of embryos that fell into 
each of the three categories of relative fluorescence intensity at the MTJ. Strong pY-397 FAK staining at 
the MTJ in spns1-/- larvae. Note that pY-397 FAK staining is very weak at the MTJ in WT larvae. (F) 
Quantification of the percent of embryos that fell into each of the three categories of relative fluorescence 
intensity at the MTJ. pY-397 FAK staining intensity was significantly reduced at the MTJ in itga6 
MOS;spns1-/- larvae compared to spns1-/- larvae. Note strong pY-397 FAK staining at the MTJ in itga6 
















 2.3.6. Laminin-111 binding induces increased FAK activity in spns1-/- muscle 
 Integrin binding to its extracellular ligands induces phosphorylation of the intracellular protein 
Focal adhesion kinase (FAK) at tyrosine 397, thereby promoting increased FAK activity (Calalb et al., 
1995; Guan et al., 1991; Hamadi et al., 2005). Thus, we asked whether laminin 111 binding to integrin 
α6β1 induces phosphorylation of FAK at tyrosine 397 in spns1-/- muscle. We stained for pY-397-FAK in 
spns1-/- mutants and WT controls at 3.5 dpf. Relative pY-397-FAK staining at the MTJ was significantly 
stronger in the spns1-/- embryos compared to the WT controls at 3.5 dpf (p-value < 0.001) (Figure 4E). 
Additionally, integrin binding to its intracellular activators can induce polymerization of extracellular 
ligands (Goody et al., 2015; Vinogradova et al., 2002). Thus, we asked whether laminin 111 binding to 
integrin α6β1 induces increased FAK activity, or whether intracellular activation of integrin α6β1 
induces laminin 111 polymerization at the MTJ in spns1-/- muscle. We injected itga6 MOs into both 
spns1-/- mutants and WT controls to generate itga6 MOs;spns1-/- mutants and itga6 MOs;WT controls. We 
stained for pY-397-FAK in uninjected WT controls, itga6 MOs;WT controls, uninjected spns1-/- mutants, 
and itga6 MOs;spns1-/- mutants at 3.5 dpf (Figure 4A-D3). Relative pY-397-FAK staining was 
significantly stronger at the MTJ in itga6 MOs;WT controls compared with uninjected WT  controls at 3.5 
dpf (p-value < 0.01) (Figure 4F). Relative pY-397-FAK staining was significantly weaker at the MTJ in 
itga6 MOs;spns1-/- mutants compared with uninjected spns1-/-  mutants at 3.5 dpf (p-value = 0.04). These 
data suggest that integrin α6β1 binding to laminin 111 induces phosphorylation of FAK at tyrosine 397 in 
spns1-/- muscle, thereby promoting increased FAK activity. 
 2.3.7.  Muscle degeneration is caused by sarcolemmal instability 
Phosphorylation of FAK occurs in an adhesion-dependent manner and increased laminin 111 
promotes muscle fiber-ECM adhesion (Calalb et al., 1995; Van Ry et al., 2014). Therefore, increased 
phosphorylation of FAK at tyrosine 397 and increased laminin 111 expression in spns1-/- muscle indicates 
stable muscle fiber-ECM attachments at the MTJ. Thus, we asked whether fiber detachments were due to 
failure to maintain sarcolemmal integrity rather than failure to maintain adhesion at the MTJ external to 
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the sarcolemma. We used cell impermeable Evans blue dye (EBD), which only fills muscle fibers when 
sarcolemmal integrity is compromised, and beta-Dystroglycan (DG) antibody staining to distinguish 
between these two etiologies (Hall et al., 2007). Detection of the membrane-integral protein beta-DG at 
the detached ends of retracted fibers suggests adhesion failure at the MTJ, while beta-DG retained at the 
MTJ indicates failure to maintain sarcolemmal integrity (Bassett et al., 2003). EBD was observed in 
retracted fibers as well as long, attached fibers in spns1-/- mutants at 3.5 dpf (Figure 5B-C). Beta-DG 
localized to MTJs in WT controls (Figure 5D-D3). The proportion of spns1-/- mutants with fiber 
detachments showing the retention of beta-DG at the MTJ was significantly greater than the proportion of 
spns1-/- mutants showing the retention of beta-DG at the detached ends of retracted fibers (p-value = 
0.0002) (Figure 5G). Additionally, the proportion of segments per spns1-/- mutant with fiber detachments 
showing retention of beta-DG at the MTJ was significantly greater than the proportion of segments 
showing the retention of beta-DG at the detached ends of retracted fibers (p-value < 0.0001) (Figure 5H). 















Figure 2.5. Sarcolemmal instability and increased MMP-9 expression. (A-B1) Anterior left, dorsal top, 
side-mounted, live 3.5 dpf larvae injected with 1% Evans Blue Dye (EBD) (pseudo-colored blue) at 3 dpf. 
White boxes in A and B correspond to zoomed-in numbered panels A1 and B1, respectively. (A-A1) WT 
larva. EBD is in the bloodstream (blue arrowheads). (B-B1) Spns1-/- larva. EBD permeates long muscle 
fibers (white arrows in B and B1) (C) Quantification of the relative length of EBD-penetrated myofibers. 
(D-F3) Anterior left, dorsal top, side-mounted, 3.5 dpf larvae stained with phalloidin (pseudo-colored 
fuchsia) to visualize actin and anti-beta-DG antibodies (green). Lettered panels show phalloidin and beta-
DG channels merged. White boxes correspond to numbered panels on the right. Panels numbered 1 show 
zoomed-in images of phalloidin staining only. Panels numbered 2 show zoomed-in images of beta-DG 
staining only. Panels numbered 3 show zoomed-in images of phalloidin and beta-DG channels merged. 
(D-D3) WT larva. Fibers remained long and beta-DG is localized to the MTJ. (E-E3) Spns1-/- larva. 
White arrows in E1-E3 point to retracted fiber unaccompanied by beta-DG. (F-F3) Spns1-/- larva. White 
arrows in F1-F3 point to retracted fibers that retained beta-DG at their detached ends. (G) Quantification 
of the percent of spns1-/- larvae with fiber detachments showing the retention of beta-DG by the fiber. (H) 
Quantification of the proportion of segments / spns1-/- larva with fiber detachments showing the retention 
of beta-DG by the fiber. (I-L3) Anterior left, dorsal top, side-mounted, embryos / larvae stained with 
phalloidin (pseudo-colored fuchsia) to visualize actin and anti-MMP-9 antibodies (green). Lettered panels 
show phalloidin / MMP-9 channels merged. White boxes correspond to numbered panels on the right. 
Panels numbered 1 show zoomed-in images of phalloidin staining only. Panels numbered 2 show 
zoomed-in images of MMP-9 staining only. Panels numbered 3 show zoomed-in images of phalloidin and 
MMP-9 channels merged. (I-I3) WT embryo at 1 dpf. White arrowheads in I1-I3 point to MMP-9. (J-J3) 
WT larva at 3.5 dpf. MMP-9 is not detected in muscle. (K-K3) Spns1-/- embryo at 1 dpf. (L-L3) Spns1-/- 
larva at 3.5 dpf. White arrowheads in K1-K3 and L1-L3 point to MMP-9. (M) q-RT PCR for relative 
transcript abundance of MMP-9 in 3.5 dpf larvae. (N) Quantification of the percent of embryos / larvae 
that fell into each of the three categories of relative fluorescence intensity. * p < 0.05, ** p < 0.01, *** p 





2.3.8. Increased expression of matrix metalloproteinase-9 (MMP-9) 
In the zebrafish model of Duchenne muscular dystrophy (DMD), loss of sarcolemmal integrity 
precedes the detachment of muscle fibers from the basement membrane at the MTJ (Hall et al., 2007). 
Increased levels of MMP-9 are associated with the pathogenesis of DMD in the mdx mouse model, the 
canine X-linked muscular dystrophy in Japan (CXMDJ) model, and muscle biopsies from human DMD 
patients (Fukushima et al., 2007; Kherif et al., 1999; Nadarajah et al., 2011). The laminin α1 chain of the 
laminin 111 protein promotes the production and activity of MMP-9, while FAK-induced signaling has 
been shown to upregulate MMP-9 expression (Chen and Li, 2009; Corcoran et al., 1995; Jia et al., 2011; 
Kikkawa et al., 2013). Since increased MMP-9 levels are associated with the pathogenesis of DMD, and 
laminin 111 and FAK are known to stimulate the expression of MMP-9, we asked whether MMP-9 shows 
increased expression in spns1-/- mutants at 3.5 dpf. We quantitatively analyzed transcription of MMP-9 
using quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR). We found that 
transcription of MMP-9 is upregulated 15.1 fold in spns1-/- mutants compared to WT controls at 3.5 dpf 
(Figure 5M, Table 2.2.). We used immunohistochemistry to analyze the protein expression of MMP-9 in 
spns1-/- muscle. We stained for MMP-9 in spns1-/- mutants and WT controls at 1 dpf and 3.5 dpf. MMP-9 
staining was detected in spns1-/- and WT control muscle at 1 dpf (Figure 5I-I3, K-K3). MMP-9 staining 
was not detected in WT control muscle at 3.5 dpf (Figure 5J-J3). These findings are mostly consistent 
with previously described zebrafish mmp9 gene expression patterns (Yoong et al. 2006). MMP-9 staining 
was detected in spns1-/- mutants at 3.5 dpf, although weaker than MMP-9 staining detected in spns1-/- 
mutants at 1 dpf (p-value = 0.15) (Figure 5N). Relative MMP-9 staining was significantly stronger in 
spns1-/- mutants compared with WT controls at 3.5 dpf (p-value < 0.01) (Figure 5N). These data indicate 
that MMP-9 is increased at the transcription and protein levels in spns1-/- muscle at a time when MMP-9 
is normally not expressed. 
2.3.9. TWEAK-Fn14 signaling axis regulates increased MMP-9 expression  
 MMP-9 is produced in response to cytokines released by degenerating muscles (Kherif et al., 
1999). Increased protein expression of the cytokine TWEAK is detected in degenerating muscle fibers 
	 40	
(Morosetti et al., 2012). Thus, we asked whether TWEAK shows increased expression in spns1-/- mutants 
at 3.5 dpf. We quantitatively analyzed transcription of TWEAK using qRT-PCR. We found that 
transcription of TWEAK is upregulated 34.2 fold in spns1-/- mutants compared to WT controls at 3.5 dpf 
(Table 2.2.). Next we asked whether TWEAK induces MMP-9 gene expression in spns1-/- mutants. 
TWEAK-induced signaling involves the binding of TWEAK to its receptor, fibroblast growth factor-
inducible 14 (Fn14) (Roos et al., 2017). The small molecule inhibitor aurintricarboxylic acid (ATA) 
blocks TWEAK-induced signaling downstream from the TWEAK-Fn14 complex (Roos et al., 2017). 
Although TWEAK-Fn14 signaling is not required for normal development in mice, we chose to 
administer ATA beginning at 2 dpf to avoid potential disruption of muscle development (Maecker et al., 
2005). We treated spns1-/- mutants and WT controls continuously with 100 µM ATA (with 0.1% EtoH) 
beginning at 2 dpf and fixed them at 3.5 dpf. This dose was based on a previous zebrafish study showing 
that 100 µM ATA caused no significant damage to embryos, while concentrations above 100 µM ATA 
caused embryo death (Kurusamy et al., 2017). Control spns1-/- and WT larvae were treated continuously 
with 0.1% EtOH beginning at 2 dpf and fixed at 3.5 dpf. We stained for MMP-9 in spns1-/- and WT 
larvae. MMP-9 staining was not detected in WT controls treated with 0.1% EtOH or 100 µM ATA 
(Figure 6E-F3, I). MMP-9 staining was detected in spns1-/- mutants treated with 0.1% EtOH; however, 
MMP-9 staining was not detected in spns1-/- mutants treated continuously with 100 µM ATA (Figure 6G-
I). These data suggest that the TWEAK-Fn14 signaling axis may regulate MMP-9 expression in spns1-/- 
mutants. TWEAK induces gene expression of MMP-9 via the activation of NF-kB and AP-1 transcription 
factors in skeletal muscle (Li et al., 2009). Thus, we used the Tg(NF-kB:EGFP) zebrafish line to ask 
whether TWEAK-induced activation of NF-kB is detected in spns1-/- mutants (Kanther et al., 2011). The 
Tg(NF-kB:EGFP) line was crossed into the spns1+/- line to detect NF-kB activity in spns1-/- mutants. 
Previous work from our lab showed that zebrafish continuously exposed to 2% EtOH from 30 hpf - 3dpf 
exhibit increased NF-kB activity as evidenced by increased GFP expression in muscle fibers (Coffey et 
al., 2018). Hence, we used WT embryos exposed to 2% EtOH from 30 hpf - 3.5 dpf as a positive control. 
Tg(NF-kB:EGFP);spns1-/- mutants, Tg(NF-kB:EGFP);WT negative controls, and Tg(NF-kB:EGFP);WT 
	 41	
positive controls were fixed  at 3.5 dpf. Muscle fibers in Tg(NF-kB:EGFP);WT negative controls 
expressed significantly less GFP at 3.5 dpf compared with muscle fibers in Tg(NF-kB:EGFP);WT 
positive controls (p-value < 0.0001) (Figure 6A-B1, D). Muscle fibers in Tg(NF-kB:EGFP);spns1-/- 
mutants also expressed significantly less GFP at 3.5 dpf compared with muscle fibers in Tg(NF-
kB:EGFP);WT positive controls (p-value < 0.0001) (Figure 6B-C1, D). There was no significant 
difference of GFP expression in muscle fibers between the Tg(NF-kB:EGFP);spns1-/- mutants and Tg(NF-
kB:EGFP);WT negative controls (p-value = 0.5059) (Figure 6D). These data suggest that TWEAK 
induces gene expression of MMP-9 independent of NF-kB activation in spns1-/- mutants.  
2.3.10. Inhibition of TWEAK-Fn14 signaling does not reduce muscle degeneration 
 Inhibition of TWEAK signaling improves muscle atrophy associated with a variety of conditions 
(Mittal et al., 2010; Paul et al., 2012; Schiaffino et al., 2013; Yadava et al., 2016). Thus, we asked 
whether continuous ATA treatment from 2 dpf - 3.5 dpf would reduce fiber detachments in spns1-/- 
muscle.  We treated spns1-/- mutants and WT controls continuously with 100 µM ATA (with 0.1% EtoH) 
beginning at 2 dpf and fixed them at 3.5 dpf. Control spns1-/- and WT larvae were treated continuously 
with 0.1% EtOH beginning at 2 dpf and fixed at 3.5 dpf. Muscle fibers were visualized using phalloidin 
staining.  The proportion of spns1-/- mutants treated with either 0.1% EtOH or 100 µM ATA that 
displayed fiber detachments was significantly greater than the proportion of WT larvae treated with either 
0.1% EtOH or 100 µM ATA (p-value = 0.0119, p-value = 0.004, respectively) (Figure 6N). There was no 
significant difference in the proportion of larvae displaying fiber detachments between the spns1-/- 
mutants treated with 0.1% EtOH and spns1-/- mutants treated with 100 µM ATA (p-value = 0.9902) 
(Figure 6N). The severity of muscle degeneration was also similar: there was no significant difference in 
the proportion of segments displaying fiber detachments between the spns1-/- mutants treated with 0.1% 
EtOH compared to spns1-/- mutants treated with 100 µM ATA (p-value = 0.6092) (Figure 6O). These data 




Figure 2.6. TWEAK inhibition blocks MMP-9 but not muscle damage. (A-C1) Anterior left, dorsal top, 
side-mounted, 3.5 dpf larvae injected stained with phalloidin (pseudo-colored fuchsia) to visualize actin. 
Lettered panels show GFP channel only. Numbered panels show phalloidin and NF-κB-EGFP channels 
merged. (A-A1) 3.5 dpf Tg(NF-κB-EGFP) larva. (B-B1)  3.5 dpf Tg(NF-κB-EGFP) larva treated 
continuously with 2% EtOH from 30 hpf - 3.5 dpf. (C-C1) 3.5 dpf spns1-/-;Tg(NF-κB-EGFP) larva. (D) 
Quantification of NF-κB activity using mean grey values of fluorescent intensity. Tg(NF-κB-EGFP) 
larvae treated continuously with 2% EtOH had significantly higher fluorescence intensity values 
compared to Tg(NF-κB-EGFP) negative control larvae and spns1-/-;Tg(NF-κB-EGFP) larvae. (E-H3) 
Anterior left, dorsal top, side-mounted, 3.5 dpf larvae stained with phalloidin (pseudo-colored fuchsia) to 
visualize actin and anti-MMP-9 antibodies (green). Lettered panels show phalloidin and MMP-9 channels 
merged. White boxes correspond to numbered panels on the right. Panels numbered 1 show zoomed-in 
images of phalloidin staining only. Panels numbered 2 show zoomed-in images of MMP-9 staining only. 
Panels numbered 3 show zoomed-in images of phalloidin and MMP-9 channels merged. (E-E3) WT 
control larva. MMP-9 is not detected in muscle. (F-F3) WT larva treated continuously with 100 µM ATA 
from 2 - 3.5 dpf. (G-G3) Spns1-/- control larva. White arrowheads point to MMP-9. (H-H3) Spns1-/- larva 
treated continuously with 100 µM ATA from 2 - 3.5 dpf. (I) Quantification of the percent of embryos that 
fell into each of the three categories of relative fluorescence intensity. (J-M1) Anterior left, dorsal top, 
side-mounted, 3.5 dpf larvae injected stained with phalloidin (pseudo-colored fuchsia) to visualize 
actin.  White boxes in lettered panels correspond to zoomed-in numbered panels. (J-J1) WT control larva 
showing long and straight fibers. (K-K1) WT larva treated continuously with 100 µM ATA from 2 - 3.5 
dpf showing long and straight fibers. (L-L1) Spns1-/- control larva showing wavy and detached fibers. 
(M-M1) Spns1-/- larva treated continuously with 100 µM ATA from 2 - 3.5 dpf showing wavy and 
detached fibers. White arrows in L-L1 and M-M1 point to fiber detachments. (N) Quantification of the 
percent of larvae with fiber detachments (O) Quantification of the proportion of segments / larva with 






Modulation of protein turnover is important for muscle development and homeostasis. Protein 
turnover requires a balance between the rate of protein synthesis and the rate of protein degradation. The 
efficiency of protein degradation is dependent upon regulation of lysosomal pH. Our data support a 
growing body of evidence suggesting that dysregulation of lysosomal pH contributes to muscle atrophy. 
We showed for the first time that loss of the carbohydrate/H+ symporter spinster (spns1) causes muscle 
damage in zebrafish. Spns1-/- mutants exhibit re-expression of laminin 111 that is dependent on integrin 
α6β1 signaling. We showed that Shh signaling can either promote or inhibit laminin 111 expression in 
muscle basement membranes in response to different genetic backgrounds and/or developmental times. 
We showed that dysregulated lysosomal pH causes sarcolemmal damage, which coincides with increased 
TWEAK and MMP-9 expression. We found that TWEAK induces expression of MMP-9 independent of 
NF-kB signaling. Finally, we provide evidence that inhibition of TWEAK signaling does not reduce 
muscle damage in spns1-/- larvae. This result contrasts with previous data showing that inhibition of 
TWEAK reduces muscle damage. Taken together, these data indicate that dysregulated lysosomal pH has 
pleiotropic effects on zebrafish skeletal muscle. 
We report here that muscle development proceeds normally in spns1-/- mutants from 1 dpf - 3 dpf; 
however, spns1-/- larvae exhibit rapid loss of muscle fiber integrity and organization around 3.5 dpf. These 
findings are consistent with previous data showing that spns1-/- zebrafish exhibit normal embryonic 
structures, blood circulation and touch response prior to 3 dpf; however, spns1-/- larvae proceed to decline 
rapidly between 3 - 4 dpf and typically don’t survive past day 4 (Young et al., n.d.). Loss of spns1 has 
been linked to dysregulated lysosomal pH (Rong et al., 2011). Additionally, dysregulation of lysosomal 
pH has been shown to cause muscle atrophy induced by the antimalarial drug Chloroquine (Wibo and 
Poole, 1974). Loss of cathepsin D-mediated lysosomal protein degradation, which requires a pH of 4.5 - 
5, has also been linked to muscle atrophy in both human patients and zebrafish (Follo et al., 2013; 
Hersheson et al., 2014). Previous studies have shown that loss of spns1 contributes to impaired cathepsin 
D activity; whereas increased spns1 promotes cathepsin D activity (Rong et al., 2011; Yanagisawa et al., 
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2017). Thus, it is not surprising that spns1-/- larvae exhibit muscle degeneration. Interestingly, a previous 
study showed that EtOH treatment increases lysosomal pH in rat hepatocytes, thereby causing 
significantly reduced protein degradation (Kharbanda et al., 1997). We recently found that ethanol 
exposure causes muscle damage in zebrafish. It will be interesting to determine if dysregulated lysosomal 
pH contributes to EtOH-induced muscle degeneration in zebrafish.  
Laminin 111 is a principal ECM component that is required for the formation of muscle during 
embryonic development. After initial muscle development laminin 111 is replaced with laminin 211. In 
zebrafish, laminin 111 expression is restricted to the eye, pectoral fins and neural structures in the head by 
2 dpf (Sztal et al., 2011). Surprisingly, we detected laminin 111 re-expression in spns1-/- muscle around 
3.5 dpf. Given the requirement of Shh signaling for laminin 111 expression in developing muscle, we 
asked whether Shh signaling was also required for laminin 111 re-expression in spns1-/- muscle. We found 
that Shh signaling was not required for laminin 111 re-expression in spns1-/- muscle; however, blocking 
Shh signaling induced ectopic expression of laminin 111 in WT muscle. We speculate that Shh signaling 
may repress laminin 111 expression in mature WT muscle. The transcriptional repressor Gli3 mediates 
Shh signaling. Gli3 is inactive when Shh signaling is present; however, when Shh signaling is blocked, 
Gli3 is proteolytically cleaved into its active repressor form Gli3R. Upon its activation, Gli3R represses 
the transcription of Shh target genes. The transcription factor Hoxa1 is transcriptionally regulated by 
Gli3R (Rouillard et al., 2016). We hypothesize that Shh-induced transcription of the gene Hoxa1 mediates 
repression of laminin 111 in mature WT muscle, while Gli3R-induced transcriptional repression of 
Hoxa1, in response to cyclopamine treatment, leads to the derepression of laminin 111 in WT muscle. 
This hypothesis is based on previous data showing that Hoxa1-deficient cells exhibit increased mRNA 
expression levels of lama1, lamb1, lamc1, klf5, sox17, and sox7 (Martinez-Ceballos et al., n.d.). Whereas 
the genes lama1, lamb1 and lamc1 encode the three laminin chains that constitute laminin 111; the genes 
klf5, sox17 and sox7 encode three transcription factors that bind the enhancer and promoter regions of the 
lama1 gene, thereby activating lama1 transcription (Niimi et al., 2004; Piccinni et al., 2004). Shh 
signaling is dependent on the endocytosis and subsequent lysosomal degradation of the Shh receptor 
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Ptch1. Previous data has shown that chloroquine-induced dysregulation of lysosomal pH blocks 
endocytosis and degradation of Ptch1, thereby inhibiting Shh signaling (Yue et al., 2014). Since loss of 
spns1 results in dysregulated lysosomal pH, we speculate that Shh signaling is impaired in spns1-/- larvae. 
It will be interesting to determine if laminin 111 re-expression is similarly regulated in spns1-/- muscle and 
cyclopamine-treated WT muscle.  
Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases, are known to 
cleave all ECM proteins. MMP gene expression and activity is tightly regulated during development and 
homeostasis; however, changes in MMP expression and activity occur in many diseases (Brkic et al., 
2015). With respect to muscle diseases, it has been shown that MMP-2 and MMP-9 play an important 
role in the pathogenesis of DMD (Dahiya et al., 2011; Fukushima et al., 2007). Given that both spns1-/- 
larvae and the zebrafish model of DMD show muscle damage that results from sarcolemmal instability, 
we asked whether MMP-2 and MMP-9 might participate in muscle degeneration induced by loss of 
spns1. MMP-9 mRNA and protein levels were increased in spns1-/- larvae compared to WT controls; 
whereas MMP-2 mRNA levels were decreased in spns1-/- larvae compared to WT controls (Table 2.2.). 
Our data suggest that regulation of MMP-2 and MMP-9 expression varies depending on disease context. 
The cytokine TWEAK has been shown to promote MMP-9 expression and muscle damage in multiple 
forms of muscle atrophy (Dogra et al., 2007; Mittal et al., 2010; Tajrishi et al., 2014); however, there is 
no evidence of altered TWEAK expression or activity in DMD. Interestingly, it has been shown that 
TWEAK-treated C2C12 myotubes show significantly increased MMP-9 mRNA and protein levels and 
significantly decreased MMP-2 mRNA and protein levels compared with untreated myotubes (Li et al., 
2009). These findings support our speculation that increased TWEAK expression mediates increased 
MMP-9 expression in spns1-/- larvae. TWEAK induces gene expression of MMP-9 via the activation of 
NF-kB and AP-1 transcription factors in skeletal muscle (Li et al., 2009). We did not detect NF-kB 
activity in spns1-/- muscle at 3.5 dpf. Interestingly, loss of spns1 leads to activation of the JNK/AP-1 
signaling pathway in Drosophila muscle (Milton et al., 2011). NF-kB signaling is dependent on the 
lysosomal degradation of IκB inhibitory proteins that bind and retain NF-κB in the cytoplasm. 
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Dysregulation of lysosomal pH inhibits degradation of IκBs, which in turn blocks NF-κB activity (Rapino 
et al., 2015). Although we can only speculate, we hypothesize that dysregulated lysosomal pH blocks NF-
kB activity in spns1-/- larvae and TWEAK induces MMP-9 expression via the activation of AP-1. Given 
that inhibition of TWEAK has been shown to reduce muscle atrophy, we asked if blocking the TWEAK 
signaling pathway was sufficient to reduce muscle defects in spns1-/- larvae. We found that selective 
inhibition of the TWEAK signaling pathway was not sufficient to reduce muscle damage in spns1-/- 
larvae. We speculate that muscle damage in spns1-/- larvae is caused by a combination of factors. It will be 
interesting in the future to determine the mechanisms underlying loss of sarcolemmal integrity in 
zebrafish in response to dysregulated lysosomal pH. 
We have addressed the impact of dysregulated lysosomal pH on muscle development in 
zebrafish. Our data show that spns1-/- larvae display normal initial muscle development, which is followed 
by rapid loss of muscle integrity and altered expression of the ECM protein laminin 111. We speculate 
that laminin 111 re-expression in mature muscle is induced by the loss of Shh signaling. We show that 
spns1-/- larvae exhibit muscle damage caused by sarcolemmal instability that coincides with TWEAK-
induced MMP-9 expression independent of NF-kB activity. Inhibition of TWEAK signaling was not 
sufficient to maintain muscle integrity in spns1-/- larvae. Taken together, these data provide novel insight 












ETHANOL EXPOSURE CAUSES MUSCLE DEGENERATION IN ZEBRAFISH 
3.1. Introduction  
Ethanol (EtOH) is a teratogen that can cause multisystemic diseases at any stage of life (Haberstick 
et al., 2014). The rate of lifetime alcohol use disorders is approximately 12% in the US. Chronic exposure 
in adults (alcoholism) can impair motor skills and cause fatigue, pain, and cramping (Rehm, 2011). These 
symptoms are similar to neuropathy. Children with fetal alcohol spectrum disorders (FASD), which arise 
from maternal consumption of alcohol during pregnancy, exhibit compromised motor skills and full body 
weakness (Memo et al., 2013). These symptoms are also attributed to neurological defects. FASD occurs 
in about 1 out of every 1000 live births (“Fetal Alcohol Syndrome—Alaska, Arizona, Colorado, and New 
York, 1995-1997,” 2002). In addition to the effect of EtOH on the nervous system, data indicate that 
skeletal muscle may also be affected by EtOH. Alcoholism in adults can cause a 30% reduction in muscle 
mass. Early life stage exposure to EtOH causes skeletal muscle necrosis in chick embryos, decreases both 
fiber number and fiber size in rat pups born to EtOH-treated mothers, and decreases fiber size in zebrafish 
embryos exposed to EtOH during primary muscle development (Chaudhuri, 2004; David and 
Subramaniam, 2005; Sylvain et al., 2010). Adult zebrafish exposed to EtOH have decreased muscle fiber 
size and exhibit abnormal behavior that varies between strains (Dlugos and Rabin, 2003; Khayrullin et al., 
2016). The effects of EtOH exposure between primary muscle development and adulthood are not 
understood.   
Zebrafish are an ideal model for studying the effects of EtOH exposure on skeletal muscle after 
primary muscle development. Zebrafish skeletal muscle is structurally similar to that of other vertebrates, 
with individual muscle fibers and segmentally reiterated groups of muscle fibers surrounded by distinct 
and dynamic regions of extracellular matrix (ECM) (Bajanca et al., 2004; Bentzinger et al., 2013; Costa et 
al., 2008; Deries et al., 2012; Gillies and Lieber, 2011; Marques and Thorsteinsdóttir, 2013; Snow and 
Henry, 2009). An important substructure in the muscle ECM is the myotendinous junction (MTJ). The 
MTJ serves as the site of force transmission from muscle to bone and is conserved in fish and mammals 
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(Gemballa and Vogel, 2002). The Dystrophin-glycoprotein complex (DGC) is one adhesion complex that 
anchors muscle fibers to laminin at the MTJ (Han et al., 2009). Dystrophin is the DGC component that 
provides a critical link between the muscle cell membrane (sarcolemma) and the cytoskeleton. 
Duchenne/Becker muscular dystrophy (DMD), results from mutations in dystrophin (Hoffman et al., 
1987). Mutations in the laminin a2 gene cause congenital muscular dystrophy with merosin deficiency 
(Tomé et al., 1994). Despite the fact that these two muscular dystrophies result from mutations in 
components within the same adhesion complex, zebrafish and mammalian models for these two diseases 
showed that the cellular pathology underlying their muscle degeneration is different (Hall et al., 2007; 
Matsuda et al., 1995; Straub et al., 1997). In the zebrafish model of DMD, damage to the sarcolemma is 
observed before muscle fibers detach from the ECM at the MTJ (Hall et al., 2007). In contrast, muscle 
fibers in the zebrafish model of merosin-deficient congenital muscular dystrophy detach from the MTJ in 
the absence of sarcolemmal damage (Hall et al., 2007). Thus, the primary cause of muscle degeneration in 
dystrophin-null sapje mutant zebrafish is sarcolemmal damage. In contrast, the primary cause of muscle 
damage in laminin a2 mutant zebrafish is failure of adhesion of muscle fibers to the MTJ. We found that 
human influenza A virus causes both sarcolemmal damage and disrupts muscle fiber adhesion to the MTJ, 
indicating that these modes of damage are not mutually exclusive (Goody et al., 2017).   
In this study, we show that EtOH treatment after primary muscle development disrupts muscle 
homeostasis and causes muscle degeneration. Similar to previous reports, the penetrance and severity of 
EtOH-induced muscle damage was somewhat variable (Dlugos and Rabin, 2003; Sylvain et al., 2010). 
Despite this variability, the severity of muscle damage caused by EtOH exposure significantly decreased 
by 48 hpf, suggesting that muscle becomes more refractory to EtOH exposure as development proceeds. 
EtOH treatment caused sarcolemmal damage and disrupted adhesion of muscle fibers to the MTJ. 
Interestingly, neither a treatment that improves pathology in zebrafish with sarcolemmal damage 
(Trichostatin A (TSA) treatment) nor a treatment that improves pathology in zebrafish with disrupted 
muscle-MTJ adhesion (Paxillin overexpression) was beneficial in EtOH-exposed zebrafish. EtOH 
treatment triggered a robust, pro-inflammatory cellular response as indicated by aberrant activation of 
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NF-kB muscle. Taken together, these data suggest that EtOH exposure induces cellular 
stress, sarcolemmal damage, and disrupts muscle fiber-MTJ adhesion. 
3.2. Materials and Methods 
3.2.1. Zebrafish Husbandry, Transgenic Lines, and Mutant Lines 
Zebrafish embryos were retrieved from natural spawns of adult zebrafish maintained on a 14-h 
light/10-h dark cycle. Strains used in this study were AB, Tg(actb2:pxn-EGFP)mai1 (Goody et al., 
2012), Tg(hsp70l:pxn-EGFP), Tg(Nf-kB:EGFP)nc1 (Kanther et al., 2011), tp53M214K (Berghmans et al., 
2005), and sapjeta222a (Bassett and Currie, 2004). Embryos were grown in embryo rearing media (1X 
ERM) with methylene blue at 28.5 or 33 degrees Celsius and staged according to (Kimmel et al., 1995). 
All protocols conformed to the University of Maine Institutional Animal Care and Usage Committee’s 
Guidelines that do not require permission for the use of zebrafish 3 days old and younger.  
3.2.2. Ethanol (EtOH) and Trichostatin A (TSA) Treatment 
EtOH dilutions were chosen based on (Sylvain et al., 2010). Solutions of 2% EtOH diluted in 1X 
ERM from either 95% or 100% EtOH stocks were continuously administered beginning at different 
stages of development (24, 30, 36, or 48 hpf) through 72 hpf. Treatments with the histone deacetylase 
(HDAC) inhibitor TSA were carried out according to (Johnson et al., 2013). TSA was dissolved in either 
DMSO or EtOH. TSA (200 nM) was diluted in 1X ERM and administered continuously from 24–
72 hpf alone or from 24–30 hpf alone and then concurrently with 2% EtOH from 30–72 hpf. Embryos 
were dechorionated prior to EtOH or TSA administration. All solutions were changed daily.  
3.2.3. Heat Shock Treatment 
Heat shock was done at 6 or 24 hpf in a 37–38 degrees Celsius incubator for 1–2 h. All heat shock-
treated embryos were screened using a GFP 470 filter on a Zeiss Discovery.V12 microscope to identify 
fluorescent transgenic embryos.  
3.2.4. Evans Blue Dye (EBD) Injection 
Zebrafish were anesthetized in 0.16 mg/mL tricaine in 1X ERM and side mounted on 1% agarose-
lined Petri dishes in a minimal volume of liquid. EBD (1% w/v) was dissolved in a 0.9% saline solution. 
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Injection needles were pulled from glass capillary tubes containing a filament on a Sutter Flaming/Brown 
Micropipette Puller. EBD solution was loaded into injection needles and injected into the circulation of 
anesthetized ~72 hpf zebrafish using a MPPI-3 pressure injector from ASI. EBD injected zebrafish were 
maintained in 1X ERM for 6 h before live imaging.  
3.2.5. Immunohistochemistry 
Zebrafish embryo fixation, phalloidin staining, and beta-Dystroglycan immunohistochemistry was 
done according to (Goody et al., 2017). 
3.2.6. Imaging 
Images were taken on a Zeiss Axio Imager Z1 microscope with a Zeiss ApoTome attachment or an 
Olympus Fluoview IX-81 inverted microscope with FV1000 confocal system. Embryos were side 
mounted in 80% glycerol/20% PBS and viewed with the 20× objective. Exposure times were kept 
constant throughout the imaging of an experiment allowing for the comparison of fluorescent levels 
between images. Live imaging for EBD experiments involved side mounting ~78 hpf zebrafish embryos 
in 0.4% low melt agarose containing 0.16 mg/mL tricaine and imaging via confocal microscopy. Linear 
adjustments were made to images in Adobe Photoshop and figures were collated in Adobe Illustrator. 
3.2.7. Analysis and Statistics 
Statistical comparisons of two groups were conducted with student t-tests. Statistical comparisons of 
multiple groups were determined using ANOVA followed by Tukey’s honest significant difference 
multiple comparisons test. For ANOVA details, please see the supplementary materials. Statistical 
analysis was done using Prism 7 or Microsoft Excel. 
3.3. Results 
3.3.1. Late embryonic exposure to EtOH causes muscle damage in zebrafish 
Zebrafish primary muscle development entails the elongation of short muscle precursor cells into 
long myofibers that attach to the ECM at the MTJ and undergo fusion to generate myotubes (Snow et al., 
2008). This process occurs by 24 post fertilization (hpf) (Figure 1A–C). Exposure to 2 or 2.5% EtOH 
during primary muscle development (8–24 hpf) results in smaller muscle fibers and abnormally wide 
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MTJs (Sylvain et al., 2010). We asked if muscle integrity would be disrupted in zebrafish that were 
treated with EtOH after primary muscle development during a period of muscle growth (Figure 1A). We 
first assessed survival and found that treatment with 0–2% EtOH did not drastically affect survival at 
72 hpf (Figure 1D). In contrast, most zebrafish treated with 2.5% EtOH died by 72 hpf (Figure 1D). 
Exposure to lower concentrations of EtOH (0.5–1%) did not cause gross morphological phenotypes 
(Figure 1E–G1). Exposure to 1.5% EtOH or higher resulted in fully penetrant pericardial edema (Figure 
1H–I1 n = 52/52 and 53/53 for 1.5 and 2% EtOH, respectively). EtOH exposure also caused muscle 
damage. Control zebrafish had linear, organized muscle fibers at 24 hpf (Figure 1C, white arrow) and at 
3 dpf (Figure 1J–J1). EtOH treatment caused muscle fiber degeneration (Figure 1K–K1, white arrows) 
although there was not a clear dose-dependent effect (Figure 1L,M). These data suggest that EtOH 
negatively affects skeletal muscle homeostasis in zebrafish. Although treatment with 2% EtOH diluted 
from a 95% (190 proof) stock resulted in fiber detachment, the penetrance of this phenotype varied across 
experimental replicates (Figure 1N,O). We also treated zebrafish with EtOH diluted from a 100% (200 
proof) stock and observed the same fiber detachment phenotype with similar variability in phenotypic 
frequency between experimental replicates (Figure 1N,O). Therefore, the variable penetrance of the 
EtOH-induced skeletal muscle phenotype is independent of pericardial edema and the stock solution used. 
All subsequent EtOH dilutions were made from the 95% stock. These data indicate that EtOH treatment 
after primary muscle development results in muscle degeneration. 
3.3.2. Zebrafish muscle is less sensitive to EtOH that is administered later 
Zebrafish primary muscle development is followed by a period of growth (Hollway et al., 2007; 
Stellabotte et al., 2007). Less obvious, but significant changes also occur in the ECM at the MTJ during 
this time (reviewed in Goody et al., 2015). Thus, we asked whether there were any critical time windows 
in which EtOH administration would result in increased muscle damage. We treated embryos 
continuously with 2% EtOH beginning at 24, 30, 36, or 48 hpf and fixed them at 3 dpf. We found a 
spectrum of muscle damage severity following EtOH administration at each time point. However, muscle 
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phenotypes were significantly less severe when zebrafish were EtOH-treated at 48 hpf (Figure 2A). To 
better analyze the muscle damage spectrum, we binned fiber detachment phenotypes into one of three 
groups: none (0 muscle segments with fiber detachments), mild (1–10 segments with fiber detachments), 
or severe (11+ segments with fiber detachments). Zebrafish treated with EtOH beginning at 24, 30, or 
36 hpf displayed the full spectrum of muscle damage severity (Figure 2B–K1). In contrast, treatment at 
48 hpf resulted in either no or only mild muscle damage (Figure 2B,L–M1). These data indicate that 















Figure 3.1. Late embryonic exposure to EtOH causes muscle damage in zebrafish. (A) Zebrafish muscle 
development timeline showing that 2% EtOH was administered after primary muscle development is 
complete. (B) Cartoon showing zebrafish muscle structure. Elongated myofibers (gray arrow) attach at 
the myotendinous junction (MTJ) (black arrow). (C) Control embryo. Muscle fibers have elongated (gray 
arrow) and attached to the MTJ (black arrow outlined in white) by 24 hpf. (D) Quantification of survival 
at 72 hpf following continuous treatment with one of six different doses of EtOH from 30–72 hpf. (E–I1) 
Brightfield images of 72 hpf zebrafish treated with one of six different doses of EtOH. Numbered panels 
are higher magnification images of zebrafish treated with the same EtOH dose as the corresponding 
lettered panels. (E–E1) 0% EtOH. Note normal heart morphology (E1, white arrow). (F–F1) 0.5% EtOH. 
Note normal heart morphology (F1, white arrow). (G–G1) 1% EtOH. Note normal heart morphology 
(G1, white arrow). (H–H1) 1.5% EtOH. Note pericardial edema (H1, black arrow). (I–I1) 2% EtOH. 
Note pericardial edema (I1, black arrow). (J–K1) Anterior left, dorsal-top, side-mounted, 72 hpf embryos 
stained with phalloidin (white) to visualize actin. White boxes in J and K correspond to zoomed-in, 
numbered panels J1 and K1, respectively. (J–J1) Control embryo. Muscle fibers remain attached to the 
MTJ. (K–K1) Embryo treated continuously with 2% EtOH from 30–72 hpf. White arrows indicate 
muscle fibers that have detached from the MTJ. (L) Quantification of the percent of EtOH-treated 
embryos at each of the EtOH treatment doses that displayed one or more fiber detachments. (M) 
Quantification of the percent of imaged segments with fiber detachments per embryo across the six 
different EtOH treatment doses. (N–O) Quantification of the variability in EtOH-induced fiber 
detachments across experimental replicates. (N) Percent of EtOH-treated embryos with at least one fiber 
detachment across three trials with either 2% EtOH diluted from 95% stock (gray bars) or 2% EtOH 
diluted from 100% stock (white bars). (O) Percent of imaged segments per embryo with fiber 
detachments across three trials with either 2% EtOH diluted from 95% stock (gray boxes) or 2% EtOH 
diluted from 100% stock (white boxes). Note the persistence of variability in muscle damage across three 
trials regardless of EtOH stock solution used. Scale bars are 50 micrometers. "e" = embryo. Error bars are 










Figure 3.2. Zebrafish muscle is less sensitive to EtOH administered later in development. (A) 
Quantification of the percent of imaged segments with fiber detachments per embryo. 2% EtOH treatment 
from 48–72 hpf caused significantly fewer segments with fiber detachments per embryo compared to 
EtOH treatment beginning at 24, 30, or 36 hpf. (B) Quantification of the percent of embryos at each of the 
four EtOH treatment time points that fell into each of the three phenotype bins. (C–N) Anterior left, 
dorsal top, side-mounted, 72 hpf embryos stained with phalloidin (white) to visualize actin. Embryos 
treated continuously with 2% EtOH from 24 hpf, 30 hpf, 36 hpf, or 48 hpf through 72 hpf showed a 
spectrum of muscle damage severity that was binned into one of three groups: None (0 segments per 
embryo with dystrophy), Mild (1–10 segments per embryo with dystrophy), or Severe (11+ segments per 
embryo with dystrophy). White boxes correspond to zoomed-in, numbered panels. (C–E1) Embryos 
continuously treated with 2% EtOH between 24 and 72 hpf showed no muscle damage (C–C1), mild 
damage (D–D1), or severe damage (E–E1). (F–H1) Embryos continuously treated with 2% EtOH 
between 30 and 72 hpf showed no muscle damage (F–F1), mild damage (G–G1), or severe damage (H–
H1). (I–K1) Embryos continuously treated with 2% EtOH between 36 and 72 hpf showed no muscle 
damage (I–I1), mild damage (J–J1), or severe damage (K–K1). (L–M1) Embryos continuously treated 
with 2% EtOH between 48 and 72 hpf showed no muscle damage (L–L1) or mild damage (M–M1). (N–
N1) Control embryo. Scale bars are 50 micrometers. "e" = embryo. Error bars are standard error of the 



















3.3.3. p53-dependent apoptosis is not required for EtOH-induced muscle damage 
To begin characterizing the muscle damage caused by EtOH treatment, we first investigated whether 
inflammation or apoptosis may be involved. Activation of the transcription factor NF-kB is part of a pro-
inflammatory, cellular stress response that can result in tissue damage. We used the Tg(NF-
kB:EGFP) zebrafish line to ask whether NF-kB-dependent signaling is altered upon EtOH exposure 
(Kanther et al., 2011). Tg(NF-kB:EGFP) zebrafish were continuously exposed to 0 or 2% EtOH from 
30 hpf on and then fixed at 3 dpf. Muscle fibers in control Tg(NF-kB:EGFP) zebrafish were long and 
linear (Figure 3A1,A2) and did not express GFP at 72 hpf (Figure 3A3–A6) (Goody et al., 2017). EtOH 
treatment increased NF-kB activity as evidenced by increased GFP expression in muscle fibers (Figure 
3B3–B6). Therefore, muscle cells respond to EtOH exposure by activating NF-kB-dependent 
transcription, which may itself contribute to muscle damage.   
The transcription factor p53 induces apoptosis in various cell types in response to stress and is 
important for muscle homeostasis (Baldelli and Ciriolo, 2016; Schwarzkopf et al., 2006). We used 
homozygous tp53M214K mutant zebrafish to ask whether EtOH causes fiber detachment via p53-dependent 
apoptosis (Berghmans et al., 2005). There were no significant differences in the proportion of treated 
embryos that displayed fiber detachments (Figure 3C, p = 0.19) or the average number of segments per 
embryo with fiber detachments (Figure 3D, p = 0.29) in EtOH-treated, homozygous tp53 mutants 
and ABs. Therefore, EtOH-induced muscle degeneration could involve pro-inflammatory NF-kB-
dependent signaling, but occurs independently of p53-mediated apoptosis.  
3.3.4. EtOH-induced muscle damage results from sarcolemmal instability 
Muscle damage in zebrafish models studied thus far can result from two distinct cellular etiologies: 
failure to maintain sarcolemmal integrity or failure to maintain adhesion at the MTJ external to the 
sarcolemma (Hall et al., 2007). Use of cell impermeable Evans blue dye (EBD), which is only taken up by 
muscle when sarcolemmal integrity is compromised, and beta-Dystroglycan (beta-DG) 
immunohistochemistry can be used to distinguish between these two etiologies (Hall et al., 2007). 
Retention of the membrane-integral protein beta-DG at the unanchored ends of retracted fibers indicates 
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MTJ adhesion failure (Bassett and Currie, 2004). As shown previously, EBD was excluded from muscle 
fibers in controls (Figure 4A). EBD was observed in retracted myofibers as well as long, attached 
myofibers in EtOH-treated zebrafish (Figure 4B–D), suggesting that EtOH 
disrupts sarcolemmal integrity. Every zebrafish with muscle damage showed EBD uptake regardless of 
whether the phenotype was mild or severe (n = 30 zebrafish over 3 trials). Beta-DG robustly localized to 
MTJs in untreated controls (Figure 4E–E3). Beta-DG also localized to MTJs in EtOH-treated embryos 
that did not have muscle degeneration (not shown). Beta-DG remained at the MTJ and did not accompany 
retracted fibers in 19/21 EtOH-treated zebrafish with the mild phenotype (Figure 4F–G3, white arrows 
indicate retracted fibers unaccompanied by beta-DG). In 2/21 EtOH-treated zebrafish with the mild 
muscle phenotype, beta-DG remained with at least one detached muscle fiber in each embryo (not 
shown). Thus, the vast majority of muscle fibers in EtOH-treated zebrafish with the mild phenotype do 
not retain beta-DG at their unanchored ends. The opposite was observed in zebrafish with the severe 
phenotype. Beta-DG was observed at the unanchored ends of retracted muscle fibers in 5/6 severe 
zebrafish (Figure 4H–I3). Taken together, these data suggest that EtOH treatment disrupts 
both sarcolemmal integrity and adhesion to the MTJ, the latter is more frequently observed in cases of 












Figure 3.3. NF-kB-dependent inflammation is present and muscle damage is independent of p53. (A1–
B6) Anterior left, dorsal top, side-mounted 72 hpf Tg(NF-kB:EGFP) embryos stained with phalloidin 
(pseudo-colored fuchsia) to visualize actin. (A1–6) 72 hpf Tg(NF-kB:EGFP) control embryo. (A1–2) 
Phalloidin channel only. (A2) Zoomed-in view corresponds to white box in A5. (A3–4) GFP channel 
only. (A4) Zoomed-in panel corresponds to white box in A5. Note low NF-kB activity in muscle fibers. 
(A5) Phalloidin and NF-kB-EGFP channels merged. (A6) Zoomed-in panel corresponds to white box in 
A5. (B1–6) 72 hpf Tg(NF-kB:EGFP) embryo treated continuously with 2% EtOH from 30–72 hpf. (B1–
2) Phalloidin channel only. (B2) Zoomed-in view corresponds to white box in B5. (B3–4) GFP channel 
only. (B4) Zoomed-in view corresponds to white box in B5. Note increased NF-kB activity in muscle 
fibers due to EtOH exposure. White arrows points to muscle fibers expressing GFP. (B5–6) Phalloidin 
and NF-kB-EGFP channels merged. (B6) Zoomed-in view corresponds to white box in B5. (C–D) 
Quantification of fiber detachment frequency within and between AB or tp53 mutant embryos treated 
with EtOH from 30–72 hpf. (C) Percent of EtOH-treated embryos displaying one or more fiber 
detachments. There was no significant difference in fiber detachment frequency between embryos 
depending on AB (gray bars) vs. tp53 mutant (white bars) genetic background at 1% EtOH. (D) Percent 
of imaged segments with fiber detachments per embryo. There was no significant difference in fiber 
detachment frequency within embryos depending on AB (gray bars) vs. tp53 mutant (white bars) genetic 



























Figure 3.4. EtOH-induced fiber detachments result from sarcolemmal instability. (A–C1) Anterior left, 
dorsal top, side-mounted, live, 78 hpf embryos treated continuously with 2% EtOH from 30–72 hpf, 
injected with 1% Evans Blue Dye (EBD) (pseudocolored blue) at 72 hpf. White boxes in A, B, and C 
correspond to zoomed-in, numbered panels A1, B1, and C1, respectively. (A–A1) Control embryo. EBD 
is in the blood stream (blue arrowheads). (B–B1) Embryo with mild fiber detachment phenotype that was 
induced by continuous treatment of 2% EtOH from 30–72 hpf. EBD is in the blood stream (blue 
arrowheads). EBD permeates some long muscle fibers (white arrows in B and B1). (C–C1) Embryo with 
severe fiber detachment phenotype that was induced by continuous treatment of 2% EtOH from 30–
72 hpf. EBD is in the blood stream (blue arrowheads). EBD permeates long (white arrows in C and C1) 
and short muscle fibers. (D) Quantification of the relative length of EBD-penetrated myofibers. EBD 
penetrated myofibers ranging from short, retracted fibers to fully elongated, diagonally arrayed, fast-
twitch myofibers in EtOH-treated embryos. (E–I3) Anterior left, dorsal top, side-mounted, 
72 hpf embryos stained with phalloidin (pseudo-colored fuchsia) to visualize actin and anti-beta-DG 
antibodies (green). Lettered panels show phalloidin and beta-DG channels merged. White boxes 
correspond to numbered panels on the right. Panels numbered 1 show zoomed-in images of phalloidin 
staining only. Panels numbered 2 show zoomed-in images of beta-DG staining only. Panels numbered 3 
show zoomed-in images of phalloidin and beta-DG channels merged. (E–E3) Control embryo. Fibers 
remained long and beta-DG is localized to the MTJ. (F–G3) Embryos treated continuously with 2% EtOH 
from 30–72 hpf showing mild fiber detachment. White arrowheads in F1–F3 and G1–G3 point to 
retracted fibers unaccompanied by beta-DG. (H–I3) Embryos treated continuously with 2% EtOH from 
30–72 hpf with severe fiber detachment. White arrowheads in H1–H3 and I1–I3 point to retracted fibers 






3.3.5. Overexpression of Paxillin does not rescue EtOH-induced muscle damage 
Muscle fibers in dystrophin-null sapje mutant zebrafish uptake EBD prior to overt muscle 
degeneration (Hall et al., 2007; Roostalu and Strähle, 2012). Previous work from our lab has shown that 
overexpression of the cytoplasmic, Integrin adaptor protein Paxillin reduces fiber detachments caused by 
failure of MTJ adhesion external to the sarcolemma (Goody et al., 2012). However, it is unknown 
whether Paxillin overexpression can reduce muscle degeneration that is preceded by sarcolemmal failure 
or whether Paxillin overexpression will benefit severe EtOH-induced muscle degeneration given that MTJ 
adhesion failure was observed in these cases. We thus asked whether Paxillin overexpression would 
reduce muscle degeneration in the contexts of EtOH exposure or in sapje mutant zebrafish. Transgenic 
zebrafish that constitutively express Paxillin (Tg(actb2:pxn-EGFP)) have normal muscle (Figure 5A–A1) 
(Goody et al., 2012). Surprisingly, Paxillin overexpression significantly increased both the prevalence and 
severity of EtOH-induced muscle damage (Figure 5B–B1,C,D, p < 0.03 and 0.02 respectively). In 
contrast, Paxillin overexpression did not significantly change the phenotype of sapje mutants (Figure 
5E, p = 0.11).  
3.3.6. Combining the HDAC inhibitor TSA with EtOH is Lethal  
The fact that Paxillin overexpression exacerbates muscle damage in EtOH-treated zebrafish but 
not sapje mutant zebrafish suggests that the underlying mechanisms of muscle damage are distinct 
despite EBD uptake in both contexts. We asked whether the HDAC-inhibitor TSA, which 
significantly reduces muscle degeneration in sapje mutant zebrafish, would alter the penetrance or 
severity of EtOH-induced muscle damage (Johnson et al., 2013). We found that the combination of 
EtOH and TSA was lethal in zebrafish (Table 3.1) before EtOH-induced fiber detachments occurred. 
Interestingly, this combination of small molecules was lethal regardless of whether the TSA was 




Table 3.1. EtOH and Trichostatin A (TSA) is a Lethal Combination for Zebrafish Embryos 
Experimental Group  Total Embryos   Embryos Alive at 
72 hpf   
%Survival  
0.66% DMSO  48  48  100  
TSA (200 nM) with 0.66% DMSO  52  52  100  
EtOH (2%)  50  36  72  
EtOH (2%) with 0.66% DMSO  27  20  74  
EtOH (2%) + TSA (200 nM) with 0.66% 
DMSO  
54  2  3.7  
 
3.3.7. EtOH exposure exacerbates muscle damage in Sapje mutant zebrafish 
Given the differences between sapje mutant and EtOH-treated zebrafish, we asked whether EtOH 
treatment would additively worsen muscle damage in sapje mutant zebrafish. Wildtype zebrafish not 
exposed to EtOH displayed normal muscle (Figure 6A). sapje mutants not exposed to EtOH or wildtype 
embryos exposed to 2% EtOH had relatively few foci of muscle damage (Figure 6B–C, white 
arrows). sapje mutants treated with 2% EtOH displayed more segments with muscle damage per embryo 
than either unexposed sapje mutants or exposed wildtypes alone (Figure 6D, white arrows). Although 
EtOH-treated sapje mutant zebrafish trended towards having more muscle degeneration, the interaction 







Figure 3.5. Paxillin overexpression does not rescue fiber detachments. (A–B1) Anterior left, dorsal top, 
side mounted, 72 hpf Tg(act2b:pxn-EGFP) embryos overexpressing Paxillin-EGFP (green) stained with 
phalloidin (pseudocolored fuchsia) to visualize actin. (A–A1) Tg(act2b:pxn-EGFP) control embryo. 
Fibers remain long and Paxillin-EGFP localizes to the MTJ. (A) GFP channel only. (A1) Phalloidin and 
GFP channels merged. (B–B1) Tg(act2b:pxn-EGFP) embryo treated continuously with 2% EtOH from 
30–72 hpf. Fibers detach from the MTJ. (B) GFP channel only. (B1) Phalloidin and GFP channels 
merged. (C) Quantification of the percentage of imaged segments/embryo that had EtOH-induced 
dystrophy. Embryos that constitutively overexpressed Paxillin-EGFP (n = 53e) had more segments with 
fiber detachments compared to AB embryos (n = 54e) after continuous treatment with 2% EtOH. (D) 
Quantification of percent of embryos with EtOH-induced fiber detachments. Fiber detachment frequency 
was significantly greater in embryos that constitutively overexpressed Paxillin-EGFP compared to AB 
embryos after continuous treatment with 2% EtOH. (E) Quantification of the proportion of imaged 
segments/embryo with dystrophy. sapje mutants that constitutively overexpressed Paxillin-EGFP (white 
bars) (n = 28e) showed no significant difference in the percent of segments that contained fiber 
detachments compared to those that did not constitutively overexpress Paxillin-EGFP (gray bars) 
(n = 23e) (p = 0.11). These data suggest that Paxillin overexpression does not reduce fiber detachments 
due to loss of sarcolemmal integrity. Scale bars are 50 micrometers. Error bars are standard error of the 















Figure 3.6. EtOH exacerbates dystrophy in sapje mutants. (A–D) Anterior left, dorsal top, side-mounted, 
72 hpf embryos stained with phalloidin (white) to visualize actin. (A) Wildtype control embryo. Muscle 
fibers are attached to the MTJ. (B) sapje mutant control embryo. A few muscle fibers detach from the 
MTJ (white arrows). (C) Wildtype embryo treated continuously with 2% EtOH from 30–72 hpf. A few 
muscle fibers detach from the MTJ (white arrow). (D) sapje mutant embryo treated continuously with 2% 
EtOH from 30–72 hpf. Note the increased number of muscle fibers detached from the MTJ (white 
arrows). (E) Quantification of fiber detachment frequency in sapje mutant embryos without and with 
EtOH exposure. sapje mutant embryos that were treated continuously with 2% EtOH showed an average 








EtOH exposure can cause a wide range of symptoms in both fetal and adult organisms. Most of what 
is known about these diseases, such as in FASD, centers on the neurological defects (Doney et al., 2016). 
Our data support a growing body of evidence suggesting that EtOH exposure damages skeletal muscle. 
We show for the first time that EtOH exposure after primary muscle development (after 24 hpf) causes 
muscle fiber detachment and degeneration in zebrafish (Figures 1 and 2). This result contrasts with the 
effects of EtOH exposure during muscle development. EtOH treatment from 8–24 hpf causes abnormally 
wide MTJs and smaller slow-twitch muscle fibers but does not cause muscle degeneration (Sylvain et al., 
2010). The mechanisms underlying muscle degeneration in zebrafish exposed to EtOH after 24 hpf are 
not known. We show that EtOH treatment results in a pro-inflammatory stress response, as indicated by 
NF-kB induction in skeletal muscle (Figure 3). EtOH treatment also causes sarcolemmal damage, which 
is visualized by uptake of EBD (Figure 4). In severely affected embryos, EtOH treatment results in failure 
of muscle end attachments to the ECM at the MTJ (Figure 4). We tested whether two approaches that 
reduce muscle damage in contexts where there is sarcolemmal damage or disrupted muscle-MTJ adhesion 
could reduce degeneration upon EtOH exposure. Neither of these approaches worked: TSA interacts with 
EtOH and is lethal, and Paxillin overexpression exacerbated muscle degeneration. Taken together, these 
data indicate that EtOH likely has pleiotropic effects on zebrafish skeletal muscle.    
We report here that there is some variation in the penetrance and severity of skeletal muscle damage 
accompanying EtOH treatment between trials. We do not know if this variation is specific to this time 
point because previous reports have compiled trials. However, it has been shown that EtOH affects 
neurobehavioral responses differently in different strains of zebrafish (Sylvain et al., 2010). Although we 
use the AB strain, we have not characterized the genetic variation in our zebrafish facility. Thus, one 
future avenue of investigation would be to determine the potential genetic modifiers that provide more 
resilience to EtOH treatment in some zebrafish.   
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The decreasing muscle damage associated with increased age at initial EtOH exposure is likely due 
to either less EtOH ingestion and/or enhanced EtOH metabolism in older embryos. It was observed that 
the concentration of EtOH within zebrafish embryos was 2.7–4.2 fold lower in 24 hpf zebrafish and 5.8–
6.2 fold less in 48 hpf zebrafish than the waterborne EtOH concentration (Lovely et al., 2014). Therefore, 
zebrafish may develop a barrier to EtOH as they age (Lovely et al., 2014). However, another study found 
the percentage of the waterborne EtOH concentration detected within embryos steadily rose from about 
15–30% when embryos were exposed to the same concentration of EtOH for increasing lengths of time 
(i.e. 10–48 h of continuous EtOH exposure) (Reimers et al., 2004). Furthermore, phenotypes of interest 
are usually elicited upon exposing adult zebrafish to 0.5–1% EtOH (v/v) whereas the EtOH dose used on 
zebrafish embryos is usually 1.5–2.5% EtOH. Together, these observations potentially contradict the idea 
that zebrafish develop a barrier to EtOH as they age.  
Muscle atrophy is a well-known symptom of many chemical or environmental insults and genetic 
perturbations. Previous studies showed that muscle fibers can detach before undergoing cell death via at 
least two distinct cellular etiologies in zebrafish models of genetic muscle diseases (Hall et al., 2007). 
Here, we show that EtOH exposure can result in mild (10 or fewer segments with muscle degeneration) or 
severe (> 10 segments with muscle degeneration) phenotypes. The fact that muscle fibers in both 
phenotypic categories uptake EBD indicates that EtOH causes damage to the muscle sarcolemma 
regardless of phenotypic severity. In contrast, disruption of muscle fiber-MTJ adhesion correlated with 
phenotypic severity. Out of 21 EtOH exposed zebrafish with mild muscle damage, only two zebrafish had 
one or more muscle fibers each that retained beta-Dystroglycan at their terminal ends. In contrast, the vast 
majority of muscle fibers retained beta-Dystroglycan at their terminal ends in zebrafish with the severe 
muscle phenotype (5/6 zebrafish, when damage is severe it is impossible to count how many fibers have 
detached). It will be interesting in the future to determine the mechanisms underlying disruption of 
muscle cell-MTJ adhesion in zebrafish with the severe phenotype.   
One hallmark of many congenital muscular dystrophies is their phenotypic variation but the 
underlying causes of variation are not known. We previously showed that the human influenza A virus 
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(IAV) damages muscle in zebrafish embryos. IAV infection significantly increases muscle degeneration 
and decreases survival in the zebrafish model of Duchenne Muscular Dystrophy (dystrophin-
deficient sapje mutant zebrafish) (Goody et al., 2017). Here we asked whether EtOH treatment similarly 
exacerbated muscle degeneration in sapje mutant zebrafish. Although we did not observe a 
significant interaction, there was a clear trend towards worsening of the sapje phenotype (Figure 6, p = 
0.06). Taken together these data highlight the utility of the zebrafish model to integrate gene 
environment interactions and suggest that environmental insults may have more pleiotropic deleterious 



















 FUTURE DIRECTIONS 
4.1. Laminin 111 re-expression 
Laminin isoforms are formed by combinations of α, β, and γ chains. The α1 chain of laminin 111 
(laminin α1β1γ1) is only expressed during initial muscle development. After initial muscle development 
laminin 111 is replaced with laminin 211 (laminin α2β1γ1). The β1 and γ1 chains continue to be 
expressed in mature muscle.  We found that developmental laminin 111 is re-expressed in spns1-/- muscle 
at a time when the mature isoform of laminin (laminin 211) is normally expressed. Previous studies have 
shown that laminin 111 expression can be induced in mature muscle through injection of the laminin 111 
protein or by inducing expression of the endogenous lama1 gene with CRISPR technology (Perrin et al., 
2017; Rooney et al., 2009). This dissertation describes the first study to show that laminin 111 can be re-
expressed in mature muscle without specifically manipulating expression of the laminin α1 chain. 
Given the requirement of Shh signaling for laminin 111 expression in developing muscle, we 
asked whether Shh signaling was also required for laminin 111 re-expression in spns1-/- muscle. We found 
that Shh signaling was not required for laminin 111 re-expression in spns1-/- muscle; however, blocking 
Shh signaling induced ectopic expression of laminin 111 in WT muscle. These results suggest that Shh 
signaling can either promote or inhibit laminin 111 expression in muscle basement membranes in 
response to different genetic backgrounds and/or developmental times. These intriguing findings have 
resulted in the formulation of new questions to answer and future directions to pursue. 
First, it is important to determine whether laminin 111 re-expression is similarly regulated in 
spns1-/- muscle and cyclopamine-treated WT muscle. An experiment to address whether laminin 111 re-
expression in spns1-/- muscle is a consequence of reduced Shh signaling would involve forced activation 
of Shh signaling in spns1-/- larvae.  Purmorphamine (PA) is a small molecule agonist of Hh signaling. 
Normally, endocytosis of the Shh-Ptch1 complex is required for Smo-induced regulation of Gli 
transcription factors; however, PA treatment can circumvent this requirement through its direct activation 
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of Smo. If PA treatment blocks laminin 111 re-expression in spns1 larvae, this suggests that Shh signaling 
represses laminin 111 signaling in both spns1-/- and WT muscle. If we find that Shh signaling regulates 
laminin 111 re-expression in spns1-/- muscle, we would proceed by identifying the mechanisms 
underlying de-repression of laminin 111 in spns1-/- muscle. 
Gli transcription factors regulate the expression of Shh target genes. Gli3 is the predominant 
transcriptional repressor. When the Shh signal is present, Gli3 is found in its inactive full-length form 
(Gli3-190); whereas when the Shh signal is blocked, Gli3 is proteolytically cleaved into its repressor form 
(Gli3-83) (Wang et al., 2000). We speculate that Gli3-83 is involved with laminin 111 re-expression. 
Experiments to address whether Gli3-83 is required for laminin 111 re-expression would involve 
inhibiting the proteolytic cleavage of Gli3-190, thus preventing the formation of Gli3-83. Inhibition of 
Gli3 proteolytic processing can be accomplished through the use of agonist and antagonist chemicals. 
Both agonist and antagonist chemicals can be used to determine whether Gli3-83 is required for 
re-expression of laminin 111. Protein kinase A (PKA) activates the degron responsible for Gli3 
processing; thus the formation of Gli3-83 is dependent upon PKA activity (Wang et al., 2000). Protein 
kinase inhibitor peptide (PKI) is a specific inhibitor of PKA activity and prevents phosphorylation of 
PKA targets. If PKI treatment blocks laminin 111 re-expression in spns1-/- larvae, this suggests that Gli3-
83 is required for laminin 111 re-expression. On the other hand, we can use the PKA agonist forskolin 
(Fsk) to ask whether Gli3-83 is involved with laminin 111 re-expresssion in WT larvae. Fsk has been 
shown to induce the appearance of Gli3-83 (Wang et al., 2000). If Fsk treatment induces laminin 111 re-
expression in WT larvae, this would suggest that laminin 111 re-expression is the result of Gli3-83-
induced transcriptional repression. Furthermore, if combined treatment of cyclopamine and PKI blocks 
laminin 111 re-expression in WT larvae, this would also suggest that Gli3-83 is required for laminin 111 
re-expression. 
The gene hoxa1 has been identified as a Gli3 target gene (Rouillard et al., 2016). Transcriptional 
repression of hoxa1 has previously been linked to increased expression of the three chains that form 
laminin 111 and of the transcription factors sox7, sox17 and klf5 (Martinez-Ceballos et al., n.d.). These 
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three transcription factors bind to the lama1 promoter and enhancer regions, thereby increasing gene 
expression of the laminin α1 chain (Niimi et al., 2004; Piccinni et al., 2004). We speculate that Gli3-83-
induced transcriptional repression of the hoxa1 gene may play a role in laminin 111 re-expression. The 
enhancer region of the hoxa1 gene contains a retinoic acid response element (RARE) and RA treatment 
activates hoxa1 gene expression (Martinez-Ceballos et al., n.d.; Martinez‐Ceballos and Gudas, 2008). 
Additionally, previous data has shown that both retinal (Ral) and RA treatment can regulate gene 
expression in zebrafish embryos (Hamade et al., 2006). Experiments to address whether repression of 
hoxa1 transcription is required for laminin 111 re-expression would involve activation of hoxa1 gene 
expression through Ral/RA treatment. If Ral/RA treatment blocks laminin 111 re-expression in spns1-/- 
muscle, this would suggest that laminin 111 re-expression is downstream of Gli3-83-induced 
transcriptional repression of hoxa1. A more direct approach to determine whether repression of hoxa1 
transcription is required for laminin 111 re-expression would be to generate a transgenic spns1-/+ line 
expressing Hoxa1 under control of a heat shock inducible promoter. If laminin 111 re-expression is 
blocked in heat shock-treated spns1-/- larvae, this would suggest that laminin 111 re-expression is 
downstream of transcriptional repression of hoxa1. Finally, it is important to quantify relative mRNA 
expression of the following genes in spns1-/- mutants compared to WT controls at 3.5 dpf: hoxa1, lama1, 
sox7, sox17, and klf5. Gene expression analysis will hopefully result in more questions to pursue.  
If we find that laminin 111 re-expression in spns1-/- muscle is not a consequence of reduced Shh 
signaling, we can proceed by working backwards from the promoter and enhancer regions of the lama1 
gene. Since we know that the transcription factors sox7, sox17 and klf5 activate lama1 expression, we 
will shift our focus from Shh signaling to the transcriptional regulation of sox7, sox17, and klf5. Increased 
laminin 111 expression has also been linked to increased malignancy of cancer cells (Kikkawa et al., 
2013). Therefore, we can explore pathways that have been characterized in cancer and/or development to 
identify which pathways may regulate expression and/or activity of these transcription factors. Once 
pathway(s) have been identified, we will proceed with chemical agonists/antagonists and genetic 
modifications to elucidate the mechanisms underlying laminin 111 re-expression in spns1-/- muscle. 
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4.2. Upregulation of Paxillin 
Muscle damage in zebrafish models studied thus far can result from two distinct cellular 
etiologies: failure to maintain sarcolemmal integrity or failure to maintain adhesion at the MTJ external to 
the sarcolemma (Hall et al., 2007). Previous work from our lab has shown that overexpression of the 
cytoplasmic, Integrin adaptor protein Paxillin reduces fiber detachments caused by failure of MTJ 
adhesion external to the sarcolemma (Goody et al., 2012). We recently showed that EtOH treatment 
causes sarcolemmal instability before fiber detachment. We also showed that overexpression of Paxillin 
did not reduce fiber detachments in EtOH-treated zebrafish. In fact, Paxillin overexpression significantly 
increased both the prevalence and severity of EtOH-induced muscle damage (Coffey et al., 2018). These 
results suggest that overexpression of Paxillin does not rescue fiber detachments caused by loss of 
sarcolemmal integrity. Paxillin contains five highly conserved LD motifs (LD 1-5) that mediate protein-
protein interactions. For example, Paxillin interacts with the cytoplasmic protein FAK through its LD2 
and LD4 motifs (Tumbarello et al., 2002). We have preliminary data showing that both the LD2 and LD4 
motifs are required for Paxillin-induced muscle damage in EtOH-treated zebrafish. Since spns1-/- larvae 
show increased FAK activity and muscle damage due to sarcolemmal instability, it will be interesting to 
determine whether Paxillin overexpression exerts similar effects in spns1-/- muscle. Interactions between 
Paxillin and its downstream effectors have been well described; therefore, experiments investigating the 
effects of Paxillin overexpression in spns1-/- muscle should provide additional future directions to explore.  
4.3. Impaired yolk absorption 
 Zebrafish embryonic growth is dependent on nutrients and energy derived from the yolk. The 
yolk consists of modified lysosomes called yolk granules that contain yolk proteins and cathepsins. 
Cathepsins degrade yolk proteins into free amino acids, which are the preferred energy source for early 
embryos (Sullivan and Yilmaz, 2018). Additionally, yolk proteins bind phosphate, carbohydrates, lipids, 
iron, calcium, magnesium, fat soluble vitamins and hormones (Sullivan and Yilmaz, 2018). The initial 
yolk granule pH is neutral, thus impairing cathepsin activity; however, as embryogenesis proceeds, 
developmentally regulated lysosomal acidification triggers yolk degradation (Fagotto, 1995). Spns1 
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mRNA expression is restricted to the yolk cell in the developing zebrafish embryo. At 1 dpf, opaque 
material accumulates within the posterior end of the yolk extension. The opaque material continues to 
move anteriorly and fills the entire yolk by 2 dpf (Young et al., n.d.). Spns1-/- larvae exhibit impaired yolk 
absorption, which is likely a consequence of impaired cathepsin activity due to dysregulated lysosomal 
pH. Interestingly, cathepsin D knock-down in zebrafish has also been linked to impaired yolk absorption 
(Follo et al., 2011). Since nutrients and energy derived from the yolk are critical for proper muscle 
development, growth and homeostasis, we ask whether spns1-/- muscle damage is regulated by 
environmental changes, muscle-derived changes, or both. Experiments to address whether environmental 
factors influence muscle degeneration in spns1-/- larvae would involve genetic mosaic analysis or yolk 
removal.  
 Genetic mosaic analysis involves injecting WT embryos with 10,000 MW fluorescent dextrans at 
1-2 cell stage. WT cells are removed at the sphere stage and transplanted into unlabeled spns1-/- hosts. If 
muscle damage is influenced by environmental factors, we predict that WT fibers in spns1-/- hosts would 
degenerate. On the other hand, if muscle damage is due to cell-autonomous factors, we predict that WT 
fibers in spns1-/- hosts would maintain cell integrity. An alternate approach to genetic mosaic analysis 
involves the removal of yolks from WT embryos around 26 hpf, the developmental stage when we begin 
to see opaque material accumulate within the yolk extension. Preliminary experiments have shown that 
zebrafish are viable for at least three days following complete yolk removal. If muscle damage is 
influenced by environmental factors, we predict that “yolkless” WT muscle would resemble the spns1-/- 
muscle phenotype. On the other hand, if muscle damage is due to cell-autonomous factors, we predict that 
“yolkless” WT muscle would not reflect the spns1-/- muscle phenotype. Together, genetic mosaic analysis 
and yolk removal experiments should help us answer the question of whether environmental factors 
influence muscle degeneration in spns1-/- larvae.  
4.4. Influence of dysregulated lysosomal pH on muscle damage 
Dysregulated lysosomal pH has previously been linked to different forms of muscle atrophy. For 
example, increased lysosomal pH induced by the antimalarial drug chloroquine causes chloroquine 
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myopathy (Wibo and Poole, 1974). Additionally, loss of cathepsin D-mediated lysosomal protein 
degradation, which requires a pH of 4.5 - 5, has been linked to muscle atrophy in both human patients and 
zebrafish (Follo et al., 2013; Hersheson et al., 2014). Since spns1 plays a pivotal role in regulating 
cathepsin D activity through maintaining optimal lysosomal pH, it is likely that muscle damage observed 
in spns1-/- larvae results from dysregulated lysosomal pH.  However, it is important to identify which 
aspects of the spns1-/- muscle phenotype are influenced by impaired lysosomal function and which aspects 
may be regulated by other factors.  Experiments to address this future direction would involve treating 
WT embryos with drugs known to inhibit lysosomal degradation. The drugs Bafilomycin A1 and  
Chloroquine are commonly used to study the role of lysosomal acidification in cellular processes. 
Bafilomycin A1 (BFA1) acts by inhibiting the highly conserved ATP-driven proton pump vacuolar H+ 
ATPase (V-ATPase). V-ATPase generates and maintains the acidic pH required for lysosomal 
degradation. Chloroquine (CQ) acts by raising the lysosomal pH, which leads to inhibition of lysosomal 
protein degradation. We will repeat all experiments discussed in Chapter 2 using WT larvae treated with 
BFA1 or CQ. Aspects of the muscle phenotype that are shared between spns1-/- larvae and WT larvae 
treated with BAF1 or CQ are likely influenced by impaired lysosomal function. On the other hand, 
aspects of the muscle phenotype that are specific to spns1-/- larvae are likely regulated by other factors. 
An additional future direction involves the lysosomal protease cathepsin D. Both cathepsin D-knockdown 
and the loss of spns1 induce a similar phenotype in zebrafish larvae characterized by: muscle damage, 
impaired yolk absorption, lack of swim bladder formation, impaired growth, and death (Follo et al., 2013, 
2011). Because of these shared phenotypes and the requirement of spns1 for cathepsin D activity, it would 
be interesting to investigate whether other aspects of the spns1-/- muscle phenotype described in Chapter 2 
are influenced by the loss of cathepsin D. A simple approach to this investigation involves the use of the 
chemical inhibitor of cathepsin D activity, pepstatin A. Alternately, the cathepsin D morpholino could be 
used to knock down cathepsin D activity in zebrafish. Future directions involving specific inhibition of 
lysosomal degradation in otherwise normal zebrafish are instrumental to understanding the impact of 
dysregulated lysosomal pH on muscle development, growth, and homeostasis. 
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4.5. Concluding remarks 
 The future directions discussed in this chapter were by no means an exhaustive list. Additional 
future directions not covered in this chapter include rescue experiments, understanding fiber-type 
susceptibility to damage, investigating potential interactions between FAK, TWEAK, and MMP-9, 
exploring a possible role for the laminin α1 chain in the regulation of increased MMP-9 expression, and 
investigating whether the transcription factor AP-1 regulates MMP-9 expression in spns1-/- larvae.  
Finally, it is important to mention that we will need to repeat the experiments that involved the effects of 
ATA treatment on MMP-9 expression in spns1-/- larvae that were discussed in section 2.3.9. 
Unfortunately, we had issues with the anti-MMP-9 antibody that we were unable to resolve. To confirm 
our results, we will proceed by investigating the regulatory role of TWEAK signaling on MMP-9 gene 
expression using RT-qPCR to analyze relative mRNA expression. 
4.6. Making connections 
In Chapter 2, we explored three distinct aspects of the muscle phenotype in spns1-/- larvae. First, 
we showed that muscle damage is caused by loss of sarcolemmal integrity and laminin 111 is re-
expressed at the MTJ. We found that laminin 111 re-expression is dependent on laminin 111 binding to 
its receptor integrin α6, which in turn induces intracellular FAK activity. Next, we showed that MMP-9 
mRNA and protein expression are increased in spns1-/- larvae. We found that increased MMP-9 
expression is correlated with increased TWEAK mRNA expression, and inhibition of TWEAK signaling 
blocked MMP-9 protein expression. Finally, we found that inhibition of TWEAK-induced MMP-9 
expression failed to reduce muscle damage, suggesting that muscle damage in spns1-/- larvae is not 
regulated by TWEAK-induced MMP-9 expression. Here, we attempt to connect these three distinct 
aspects of the spns1-/- muscle phenotype.  
First, we attempt to connect the laminin 111/integrin α6/FAK signaling axis to TWEAK-induced 
MMP-9 expression in spns1-/- larvae. Previous data has shown that peptides within the laminin α1 chain 
of laminin 111 induce production of MMP-9 (Corcoran et al., 1995). Additionally, it has been shown that 
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laminin α1 peptides act through integrin α6 to increase protease activity (Kikkawa et al., 2013). Thus, 
laminin 111 re-expression may increase MMP-9 expression through integrin α6 signaling in spns1-/- 
muscle. Additionally, multiple lines of evidence suggest a connection between increased FAK activity 
and increased MMP-9 expression (Chen et al., 2009; Das et al., 2009). Interestingly, it has also been 
shown that constitutive activation of the cytoplasmic tyrosine kinase Src leads to increased expression of 
Fn-14, the sole signaling receptor for the cytokine TWEAK (Cheng et al., 2015). Given that Src 
phosphorylates multiple sites on FAK, Src-induced expression of Fn-14 may provide an additional 
avenue to explore. TWEAK signaling also induces the production of reactive oxygen species (ROS), 
which in turn can activate either MMP-9 or FAK (Chiarugi et al., 2003; Madrigal-Matute et al., 2015; 
Reinhard et al., 2015). Although we can only speculate, we present several lines of evidence suggesting a 
connection between the laminin 111/integrin α6/FAK signaling axis and TWEAK-induced MMP-9 
expression.  
Next, we attempt to explain our perplexing data showing that muscle damage in spns1-/- larvae is 
not regulated by TWEAK-induced MMP-9 expression. Given that dysregulated lysosomal pH is linked to 
disruption of the endocytic pathway, and the endocytic pathway is required for turnover of basement 
membrane and sarcolemmal proteins, we hypothesize that muscle damage detected in spns1-/- larvae may 
result from impaired function of the endocytic pathway rather than from TWEAK-induced MMP-9 
expression. Our speculations are also based on previous studies showing that the endocytic pathway plays 
an important role in maintaining muscle fiber integrity in muscle disease (Draviam et al., 2006; 
Hernández-Deviez et al., 2008). Thus, we predict that future experiments will implicate a regulatory role 






































































Figure A.1. Fast- and slow-twitch fiber types are susceptible to muscle damage. (A1-B2) Anterior left, 
dorsal top, side-mounted 3.5 dpf larvae stained with phalloidin (pseudo-colored fuchsia) to visualize 
actin. (A1) WT larva. Horizontally arrayed slow-twitch fibers are long and straight. (A2) WT larva. 
Diagonally arrayed fast-twitch fibers are long and straight. (B1) Spns1-/- larva showing a detached 
horizontal slow twitch fiber. (B2) Spns1-/- larva showing wavy and detached diagonal fast-twitch fibers. 
(C) Quantification of the percentage of segments / spns1-/- larva containing fiber-type specific muscle 
damage. There is no significant difference in the percent of segments that contain fast-twitch vs. slow-
twitch fiber detachments. (D) Quantification of the proportion of spns1-/- larvae containing fiber-type 
specific muscle damage. There is no significant difference in the proportion of spns1-/- larvae that contain 
fast-twitch vs. slow-twitch fiber detachments. Note that the proportion of spns1-/- larvae containing only 
fast-twitch detachments or only slow-twitch detachments was significantly greater than spns1-/- embryos 
containing both fast-twitch and slow-twitch muscle fiber detachments. * p < 0.05, ** p < 0.01, *** p < 
0.001, **** p < 0.0001. 
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